10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒    Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2023.

or

☐     Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission file number: 001-35376

OBLONG, INC.

(Exact Name of Registrant as Specified in its Charter)

Delaware	77-0312442
(State or Other Jurisdiction of Incorporation or Organization)	(I.R.S. Employer Identification No.)

25587 Conifer Road, Suite 105-231, Conifer, CO 80433

(Address of Principal Executive Offices, including Zip Code)

(303) 640-3838

(Registrant’s Telephone Number, including Area Code)

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.0001 per share	OBLG	Nasdaq Capital Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒  No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☒	Smaller reporting company ☒
	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.)

Yes ☐ No ☒

The number of shares outstanding of the registrant’s common stock as of May 9, 2023 was 2,580,370.

OBLONG, INC.

Index

PART I - FINANCIAL INFORMATION
Item 1. Financial Statements		1
	Condensed Consolidated Balance Sheets at March 31, 2023 (unaudited) and December 31, 2022	1
	Unaudited Condensed Consolidated Statements of Operations for the three months ended March 31, 2023 and 2022	2
	Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three months ended March 31, 2023 and 2022	3
	Unaudited Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2023 and 2022	5
	Notes to unaudited Condensed Consolidated Financial Statements	6
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		19
Item 3. Quantitative and Qualitative Disclosures About Market Risk		24
Item 4. Controls and Procedures		24
PART II - OTHER INFORMATION
Item 1. Legal Proceedings		24
Item 1A. Risk Factors		24
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		25
Item 3. Defaults Upon Senior Securities		25
Item 4. Mine Safety Disclosures		26
Item 5. Other Information		26
Item 6. Exhibits		27
Signatures		28

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This quarterly report on Form 10-Q (this “Report”) contains statements that are considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and its rules and regulations (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended, and its rules and regulations (the “Exchange Act”). These forward-looking statements include, but are not limited to, statements about the plans, objectives, expectations and intentions of Oblong, Inc. (“Oblong” or “we” or “us” or the “Company”). All statements other than statements of current or historical fact contained in this Report, including statements regarding Oblong’s future financial position, business strategy, budgets, projected costs and plans and objectives of management for future operations, are forward-looking statements. The words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” and similar expressions, as they relate to Oblong, are intended to identify forward-looking statements. These statements are based on Oblong’s current plans, and Oblong’s actual future activities and results of operations may be materially different from those set forth in the forward-looking statements. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from the statements made. Any or all of the forward-looking statements in this Report may turn out to be inaccurate. Oblong has based these forward-looking statements largely on its current expectations and projections about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs. The forward-looking statements can be affected by inaccurate assumptions or by known or unknown risks, uncertainties and assumptions. There are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements, including our plans, objectives, expectations and intentions and other factors that are discussed under the section entitled “Part I. Item 1A. Risk Factors” and in our consolidated financial statements and the footnotes thereto for the fiscal year ended December 31, 2022, each included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 filed with the Securities and Exchange Commission (the “SEC”) on March 21, 2023. Oblong undertakes no obligation to publicly revise these forward-looking statements to reflect events occurring after the date hereof. All subsequent written and oral forward-looking statements attributable to Oblong or persons acting on its behalf are expressly qualified in their entirety by the cautionary statements contained in this Report. Forward-looking statements in this Report include, among other things: our ability to meet commercial commitments; our expectations and estimates relating to customer attrition, the potential release of the equity financing proceeds from escrow, the future exercise of warrants, demand for our product offerings, sales cycles, future revenues, expenses, capital expenditures and cash flows; our ability to develop and launch new product offerings; evolution of our customer solutions and our service platforms; our ability to fund operations and continue as a going concern; expectations regarding adjustments to our cost of revenue and other operating expenses; our ability to finance investments in product development and sales and marketing; our ability to raise capital through sales of additional equity or debt securities and/or loans from financial institutions; our beliefs about the ongoing performance and success of our Managed Service business; statements relating to market need and evolution of the industry, our solutions and our service platforms; adequacy of our internal controls. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, those summarized below:

•the failure to obtain stockholder approval in connection with our March 2023 equity financing;

•the continued impact of the coronavirus pandemic on our business, including its impact on our customers and other business partners, our ability to conduct operations in the ordinary course, and our ability to obtain capital financing important to our ability to continue as a going concern;

•our ability to continue as a going concern;

•our ability to raise capital in one or more debt and/or equity offerings in order to fund operations or any growth initiatives;

•customer acceptance and demand for our video collaboration services and network applications;

•our ability to launch new products and offerings and to sell our solutions;

•our ability to compete effectively in the video collaboration services and network services businesses;

•the ongoing performance and success of our Managed Services business;

•our ability to maintain and protect our proprietary rights;

•our ability to withstand industry consolidation;

•our ability to adapt to changes in industry structure and market conditions;

•actions by our competitors, including price reductions for their competitive services;

•the quality and reliability of our products and services;

•the prices for our products and services and changes to our pricing model;

•the success of our sales and marketing approach and efforts, and our ability to grow revenue;

•customer renewal and retention rates;

•risks related to the concentration of our customers and the degree to which our sales, now or in the future, depend on certain large client relationships;

•increases in material, labor or other manufacturing-related costs;

•changes in our go-to-market cost structure;

•inventory management and our reliance on our supply chain;

•our ability to attract and retain highly skilled personnel;

•our reliance on open-source software and technology;

•potential federal and state regulatory actions;

•our ability to innovate technologically, and, in particular, our ability to develop next generation Oblong technology;

•our ability to satisfy the standards for continued listing of our common stock on the Nasdaq Capital Market;

•changes in our capital structure and/or stockholder mix;

•the costs, disruption, and diversion of management’s attention associated with campaigns commenced by activist investors; and

•our management’s ability to execute its plans, strategies and objectives for future operations.

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

OBLONG, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except par value, stated value, and shares)

	March 31, 2023		December 31, 2022
	(Unaudited)
ASSETS
Current assets:
Cash	$	3,714	$	3,085
Accounts receivable, net	392		415
Inventory, net	634		723
Prepaid expenses and other current assets	947		649
Total current assets	5,687		4,872
Property and equipment, net	3		3
Intangibles, net	518		604
Operating lease - right of use asset, net	99		142
Other assets	31		40
Total assets	$	6,338	$	5,661
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	207	$	184
Accrued expenses and other current liabilities	1,665		1,074
Current portion of deferred revenue	341		436
Current portion of operating lease liabilities	139		219
Total current liabilities	2,352		1,913
Long-term liabilities:
Operating lease liabilities, net of current portion	—		17
Deferred revenue, net of current portion	84		114
Total liabilities	2,436		2,044
Commitments and contingencies (see Note 11)
Stockholders’ equity:
Preferred stock Series F, convertible; $.0001 par value; $6,550,000 stated value; 42,000 shares authorized, 6,550 and zero shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively	—		—
Common stock, $.0001 par value; 150,000,000 shares authorized; 2,070,861 shares issued and 2,063,308 outstanding at March 31, 2023 and December 31, 2022	—		—
Treasury stock, 7,553 shares of common stock at March 31, 2023 and December 31, 2022	(181)		(181)
Additional paid-in capital	229,149		227,645
Accumulated deficit	(225,066)		(223,847)
Total stockholders' equity	3,902		3,617
Total liabilities and stockholders’ equity	$	6,338	$	5,661

See accompanying notes to condensed consolidated financial statements.

-1-

OBLONG, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

	Three Months Ended
	March 31,
	2023		2022
Revenue	$	1,038	$	1,532
Cost of revenue (exclusive of depreciation and amortization)	762		1,033
Gross profit	276		499
Operating expenses:
Research and development	6		1,004
Sales and marketing	218		562
General and administrative	1,169		1,690
Impairment charges	—		1,138
Depreciation and amortization	86		627
Total operating expenses	1,479		5,021
Loss from operations	(1,203)		(4,522)
Interest and other expense, net	5		6
Other income	(27)		—
Interest and other (income) expense, net	(22)		6
Loss before income taxes	(1,181)		(4,528)
Income tax expense	38		11
Net loss	(1,219)		(4,539)
Warrant Modification	25		—
Net loss attributable to common stockholders	$	(1,244)	$	(4,539)
Net loss attributable to common stockholders per share:
Basic and diluted net loss per share	$	(0.60)	$	(2.20)
Weighted-average number of shares of common stock:
Basic and diluted	2,065		2,065

See accompanying notes to condensed consolidated financial statements.

-2-

OBLONG, INC.

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

Three Months Ended March 31, 2023

(In thousands, except shares)

(Unaudited)

	Series F Preferred Stock			Common Stock			Treasury Stock
	Shares	Amount		Shares	Amount		Shares	Amount		Additional Paid-In Capital		Accumulated Deficit		Total
Balance at December 31, 2022	—	$	—	2,071,000	$	—	8,000	$	(181)	$	227,645	$	(223,847)	$	3,617
Net loss	—	—		—	—		—	—		—		(1,219)		(1,219)
Stock-based compensation	—	—		—	—		—	—		31		—		31
Proceeds from private placement, net of fees and amounts held in escrow	6,550	—		—	—		—	—		1,473		—		1,473
Balance at March 31, 2023	6,550	$	—	2,071,000	$	—	8,000	$	(181)	$	229,149	$	(225,066)	$	3,902

See accompanying notes to condensed consolidated financial statements.

-3-

OBLONG, INC.

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

Three Months Ended March 31, 2022

(In thousands, except shares)

(Unaudited)

	Common Stock			Treasury Stock
	Shares	Amount		Shares	Amount		Additional Paid-In Capital		Accumulated Deficit		Total
Balance at December 31, 2021	2,071,000	$	—	8,000	$	(181)	$	227,584	$	(201,906)	$	25,497
Net loss	—	—		—	—		—		(4,539)		(4,539)
Stock-based compensation	—	—		—	—		52		—		52
Forfeiture of unvested stock options	—	—		—	—		(84)		—		(84)
Balance at March 31, 2022	2,071,000	$	—	8,000	$	(181)	$	227,552	$	(206,445)	$	20,926

See accompanying notes to condensed consolidated financial statements.

-4-

OBLONG, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

	Three Months Ended March 31,
	2023		2022
Cash flows from operating activities:
Net loss	$	(1,219)	$	(4,539)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	86		627
Bad debt (recovery) expense	(24)		111
Non-cash lease expense from right-of-use asset	43		127
Stock-based compensation	31		52
Forfeiture of unvested stock options	—		(84)
Impairment charges - goodwill	—		1,138
Changes in operating assets and liabilities:
Accounts receivable	47		183
Inventory	89		103
Prepaid expenses and other current assets	(298)		(360)
Other assets	9		45
Accounts payable	23		294
Accrued expenses and other current liabilities	591		188
Deferred revenue	(125)		(126)
Lease liabilities	(97)		(163)
Net cash used in operating activities	(844)		(2,404)
Cash flows from investing activities:
Purchases of property and equipment	—		(11)
Proceeds from sale of equipment	—		1
Net cash used in investing activities	—		(10)
Cash flows from financing activities:
Proceeds from private placement, net of issuance costs and amounts in escrow	1,473		—
Net cash provided by financing activities	1,473		—
Increase (decrease) in cash and restricted cash	629		(2,414)
Cash and restricted cash at beginning of period	3,085		9,000
Cash and restricted cash at end of period	$	3,714	$	6,586
Supplemental disclosures of cash flow information:
Reconciliation of cash and restricted cash
Cash	$	3,714	$	6,525
Restricted cash	—		61
Total cash and restricted cash	$	3,714	$	6,586
Cash paid during the period for interest	$	2	$	—
Cash paid for income taxes	$	31	$	—
Non-cash investing and financing activities:
Warrant modification	$	25	$	—

See accompanying notes to condensed consolidated financial statements.

-5-

OBLONG, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2023

(Unaudited)

Note 1 - Business Description and Significant Accounting Policies

Business Description

Oblong, Inc. (“Oblong” or “we” or “us” or the “Company”) was formed as a Delaware corporation in May 2000 and is a provider of patented multi-stream collaboration technologies and managed services for video collaboration and network applications.

Basis of Presentation

The Company's fiscal year ends on December 31 of each calendar year. The accompanying interim Condensed Consolidated Financial Statements are unaudited and have been prepared on substantially the same basis as our annual Consolidated Financial Statements for the fiscal year ended December 31, 2022. In the opinion of the Company's management, these interim Condensed Consolidated Financial Statements reflect all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.

The December 31, 2022 year-end Condensed Consolidated Balance Sheet data in this document was derived from audited consolidated financial statements. The Condensed Consolidated Financial Statements and notes included in this quarterly report on Form 10-Q do not include all disclosures required by U.S. generally accepted accounting principles and should be read in conjunction with the Company's audited consolidated financial statements as of and for the year ended December 31, 2022 and notes thereto included in the Company's fiscal 2022 Annual Report on Form 10-K, filed with the Securities and Exchange Commission (“SEC”) on March 21, 2023 (the “2022 10-K”).

The results of operations and cash flows for the interim periods included in these Condensed Consolidated Financial Statements are not necessarily indicative of the results to be expected for any future period or the entire fiscal year.

Principles of Consolidation

The Condensed Consolidated Financial Statements include the accounts of Oblong and our 100%-owned subsidiaries (i) GP Communications, LLC (“GP Communications”), whose business function is to provide interstate telecommunications services for regulatory purposes, and (ii) Oblong Industries, Inc. All inter-company balances and transactions have been eliminated in consolidation. The U.S. Dollar is the functional currency for all subsidiaries.

Segments

The Company currently operates in two segments: (1) “Collaboration Products” which represents the business surrounding our Mezzanine™ product offerings, and (2) “Managed Services” which represents the business surrounding managed services for video collaboration and network solutions. See Note 10 - Segment Reporting for further discussion.

Use of Estimates

Preparation of the Condensed Consolidated Financial Statements in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual amounts could differ from the estimates made. We continually evaluate estimates used in the preparation of our consolidated financial statements for reasonableness. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation. The significant areas of estimation include determining the allowance for doubtful accounts, the estimated lives and recoverability

-6-

of intangible assets, the inputs used in the valuation of intangible assets in connection with our impairment test, and the inputs used in the fair value of equity-based awards.

Significant Accounting Policies

The significant accounting policies used in preparation of these Condensed Consolidated Financial Statements are disclosed in our 2022 10-K, and there have been no changes to the Company’s significant accounting policies during the three months ended March 31, 2023.

Recently Issued Accounting Pronouncements

In June 2016 the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326),” which was subsequently amended in February 2020 by ASU 2020-02, “Financial Instruments - Credit Losses (Topic 326) and Leases (Topic 842).” The amendments introduce an impairment model that is based on expected credit losses, rather than incurred losses, to estimate credit losses on certain types of financial instruments (e.g., loans and held-to-maturity securities), including certain off-balance sheet financial instruments (e.g., loan commitments). The expected credit losses should consider historical information, current information, and reasonable and supportable forecasts, including estimates of prepayments, over the contractual term. Financial instruments with similar risk characteristics may be grouped together when estimating expected credit losses. The update was effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company adopted the new guidance, as of January 1, 2023, and it did not have a material impact on the Condensed Consolidated Financial Statements.

Note 2 - Liquidity and Going Concern Uncertainty

As of March 31, 2023, we had $3,714,000 in cash and working capital of $3,335,000. For the three months ended March 31, 2023, we incurred a net loss of $1,219,000 and used $844,000 of net cash in operating activities.

Equity Private Placement

On March 30, 2023, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which we issued and sold, in a private placement transaction (the “Private Placement”), (i) 6,550 shares (the “Preferred Shares”) of our newly designated Series F convertible preferred stock, $0.0001 par value per share (the “Series F Preferred Stock”), initially convertible into up to 3,830,409 shares of our Common Stock, (ii) preferred warrants (“Preferred Warrants”) to acquire 32,750 shares of Series F Preferred Stock, and (iii) common warrants (“Common Warrants” and with the Preferred Warrants the “Investor Warrants”) to acquire up to 3,830,413 shares of Common Stock. The terms of the Series F Preferred Stock are as set forward in the Certificate of Designations of Series F Preferred Stock of Oblong, Inc. (the “Certificate of Designations”), which was filed and became effective with the Secretary of State of the State of Delaware on March 31, 2023. The Private Placement closed on March 31, 2023. Please see the discussion in Note 6 - Capital Stock for further details on the Common Warrants and Note 7 - Preferred Stock for further discussion on the Series F Preferred Stock and Preferred Warrants.

The aggregate gross proceeds of the Private Placement are expected to be $6,386,000. All of the Preferred Shares and Investor Warrants were issued at the Closing, but part of the purchase price equivalent to $4,000,000 was placed into an escrow account with American Stock Transfer & Trust Company (the “Escrow”), to be released upon our obtaining stockholder approval permitting the issuance of more than 19.99% of our outstanding shares of Common Stock at less than the Minimum Price (as defined under the Nasdaq Rules) in accordance with Nasdaq listing standards and as otherwise may be required (the “Stockholder Approval”). The Company expects to use the net proceeds from the Private Placement and the proceeds, if any, from the exercise of the Investor Warrants for general corporate purposes and potential strategic alternatives. We have not, nor has anyone on our behalf, initiated any substantive discussions directly or indirectly with any strategic alternatives partner.

In connection to the Private Placement, pursuant to an engagement letter dated March 30, 2023 (the “Engagement Letter”), between the Company and Dawson James Securities, Inc. (the “Placement Agent”), the Company agreed to (i) pay the Placement Agent a cash fee equal to 8% of the aggregate gross proceeds raised in the Private Placement, and (ii) grant to the Placement Agent warrants (the “Placement Agent Warrants”) to purchase 306,433 shares of Common Stock at an initial exercise price of $1.71 per share. Additionally, we agreed to reimburse the Placement Agent for certain expenses incurred in connection with the Private Placement and to pay certain contingent fees upon the occurrence of specified future events. Please see the discussion in Note 6 - Capital Stock for further details on the Placement Agent Warrants.

-7-

Future Capital Requirements and Going Concern

Our capital requirements in the future will continue to depend on numerous factors, including the potential release of the Escrow, the amount of revenue the Company is able to generate, customer renewal rates and the timing of collection of outstanding accounts receivable, in each case particularly as it relates to the Company’s major customers, the expense to deliver services, expense for sales and marketing, and expense for research and development. The Company believes that, in the event the Escrow is not released, based on its current projection of revenue, expenses, and cash flows, it will not have sufficient resources to fund its operations for the next twelve months following the filing of this Report. We believe additional capital will be required to fund operations and provide growth capital including investments in technology, product development and sales and marketing. To access capital to fund operations or provide growth capital, we will need to raise capital in one or more debt and/or equity offerings. There can be no assurance that we will be successful in raising necessary capital or that any such offering will be on terms acceptable to the Company. If we are unable to raise additional capital that may be needed on terms acceptable to us, it could have a material adverse effect on the Company. The factors discussed above raise substantial doubt as to our ability to continue as a going concern. The accompanying Condensed Consolidated Financial Statements do not include any adjustments that might result from these uncertainties.

Note 3 - Intangible Assets and Goodwill

Intangioble Assets

The following table presents the components of net intangible assets for our Collaboration Products reporting segment (in thousands):

	As of March 31, 2023						As of December 31, 2022
	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Developed technology	$	486	$	(121)	$	365	$	486	$	(61)	$	425
Trade names	204		(51)		153		204		(25)		179
Total	$	690	$	(172)	$	518	$	690	$	(86)	$	604

At each reporting period, we determine if there was a triggering event that may result in an impairment of our intangible assets. During the three months ended March 31, 2023, we considered the declines in revenue for the Collaboration Products reporting segment to be a triggering event for an impairment test of intangible assets for this segment. Based on the fair value of the asset group, which was determined using a market approach, no impairment charges were recorded for the three months ended March 31, 2023.

Related amortization expense was $86,000 and $580,000 for the three months ended March 31, 2023 and 2022, respectively.

Amortization expense for each of the next five succeeding years will be as follows (in thousands):

Remainder of 2023	$	260
2024	258
Total	$	518

Goodwill

During 2022, Goodwill was written down to zero with an impairment charge of $1,138,000 during the three months ended March 31, 2022, and a subsequent impairment charge of $6,229,000 during the three months ended June 30, 2022.

-8-

Note 4 - Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	March 31,		December 31,
	2023		2022
Compensation costs	$	779	$	707
Customer deposits	271		128
Professional fees	344		57
Taxes and regulatory fees	43		59
Other accrued expenses and liabilities	77		123
Rent expense	151		—
Accrued expenses and other liabilities	$	1,665	$	1,074

Note 5 - Leases

We lease three facilities in Los Angeles, California providing office space and one facility in City of Industry, California, providing warehouse space. These leases expire between 2023 and 2024. We currently occupy the warehouse space in City of Industry; however, we do not occupy any of the office space in Los Angeles. We have a sublease in place for one of the Los Angeles, California office spaces. With the exception of these spaces described above, we currently operate out of remote employment sites with a remote office located at 25587 Conifer Road, Suite 105-231, Conifer, Colorado 80433.

Lease expenses, net of common charges, for the three months ended March 31, 2023 and 2022, were $46,000 and $139,000, respectively. Sublease proceeds for the three months ended March 31, 2023 and 2022, were $16,000 and $66,000, respectively.

The following provides balance sheet information related to leases as of March 31, 2023 and December 31, 2022 (in thousands):

		March 31, 2023		December 31, 2022
Assets
	Operating lease, right-of-use asset, net	$	99	$	142
Liabilities
	Current portion of operating lease liabilities	$	139	$	219
	Operating lease liabilities, net of current portion	—		17
	Total operating lease liabilities	$	139	$	236

During the three months ended March 31, 2023 and 2022, payments of $100,000 and $173,000 were made on leases, respectively. The following table summarizes the future undiscounted cash payments reconciled to the lease liability (in thousands):

Remaining Lease Payments
2023	$	125
2024	17
Total lease payments	142
Effect of discounting	(3)
Total lease liability	$	139

The following table provides a reconciliation of activity for our right-of-use (“ROU”) assets and lease liabilities (in thousands):

-9-

	Right-of-Use Asset		Operating Lease Liabilities
Balance at December 31, 2021	$	659	$	728
Additions	11		11
Non-cash lease expense and payments	(349)		(503)
Impairment charges	(179)		—
Balance at December 31, 2022	142		236
Additions	—		—
Terminations and modifications	$	—	$	—
Non-cash lease expense and payments	(43)		(97)
Impairment charges	—		—
Balance at March 31, 2023	$	99	$	139

The ROU assets and lease liabilities are recorded on the Company’s Condensed Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022.

Note 6 - Capital Stock

Common Stock

On January 3, 2023, the Company effected a 1-for-15 reverse stock split of its Common Stock. All Common Stock share information (including treasury share information) in our Condensed Consolidated Financial Statements and has been adjusted for this stock split retrospectively for all periods represented herein.

The Company’s common stock, par value $0.0001 per share (the “Common Stock”), is listed on the Nasdaq Capital Market (“Nasdaq”), under the ticker symbol “OBLG”. As of March 31, 2023, we had 150,000,000 shares of our Common Stock authorized, with 2,070,861 and 2,063,308 shares issued and outstanding, respectively.

The Company did not issue any shares of Common Stock during the three months ended March 31, 2023.

On April 18, 2023, the Company issued 339,498 shares of Common Stock in relation to certain warrant exercises discussed below, and 177,564 shares of Common Stock related to vested RSUs discussed in Note 8 - Stock Based Compensation.

Common Stock Warrants

As described in Note 2, in connection with the Private Placement, on March 31, 2023, the Company issued the Common Warrants and Placement Agent Warrants to purchase an aggregate of 4,136,846 shares of the Company’s Common Stock. The Common Warrants and Placement Agent Warrants have a term of 5 years, commencing six months and one day from the date of issuance, and are initially exercisable for $1.71 per share. The exercise price is subject to customary adjustments for stock splits, stock dividends, stock combination, recapitalization, or other similar transactions involving the Common Stock, and subject to price-based adjustment, on a full ratchet basis, in the event of any issuances of Common Stock, or securities convertible, exercisable or exchangeable for Common Stock, at a price below the then-applicable exercise price for the Common Warrants (subject to certain exceptions). The Common Warrants and Placement Agent Warrants are exercisable for cash, provided that if there is no effective registration statement available permitting the resale of the common shares, they may be exercised on a cashless basis. Exercise of the Common Warrants and Placement Agent Warrants is subject to certain limitations, including a 4.99% beneficial ownership limitation. The fair value of the warrants was recorded within additional paid-in capital during the three months ended March 31, 2023.

-10-

Warrants outstanding as of March 31, 2023 are as follows:

Issue Date	Warrants Issued	Exercise Price		Expiration Date
October 21, 2020	34,767	$	61.20	April 22, 2023
December 6, 2020	41,667	82.35		June 7, 2023
June 28, 2021	66,667	60.00		January 4, 2024 (a)
June 28, 2021	200,000	66.00		June 28, 2024
March 31, 2023	4,136,846	$	1.71	September 30, 2028
	4,479,947

(a) On January 3, 2023, the Company and all the holders of the Series A Warrants agreed to amend the terms of the Series A Warrants to extend the termination date from January 4, 2023 to January 4, 2024. All other terms of the Series A Warrants will remain in full force and effect. The modification resulted in an incremental value adjustment, and deemed dividend, of $25,000, which was recorded within additional paid-in capital during the three months ended March 31, 2023.

On April 18, 2023, the Company entered into warrant exercise inducement offer letters with certain holders of outstanding warrants to purchase shares of the Company’s common stock originally issued on October 21, 2020, December 6, 2020, and June 28, 2021, as reflected in the table above (such holders the “Exercising Holders” and such warrants the “Existing Warrants”) pursuant to which the Exercising Holders agreed to exercise, for cash, Existing Warrants to purchase, in the aggregate, 339,498 shares of the Company’s common stock (the “Existing Warrant Shares”), in exchange for the Company’s agreement to lower the exercise price of the Existing Warrants to $1.71. The Company received net proceeds of $534,000 from the exercise of the Existing Warrants in April 2023 (net of $46,000 of financing costs). Following the exercise of the Existing Warrants, an aggregate of 3,603 Existing Warrants remained outstanding.

Warrant activity for the three months ended March 31, 2023 and the year ended December 31, 2022 is presented below.

	Outstanding
	Number of Warrants	Weighted Average Exercise Price
Warrants outstanding and exercisable, December 31, 2021	343,101	$	66.34
Warrants outstanding and exercisable, December 31, 2022	343,101	66.34
Granted	4,136,846	1.71
Warrants outstanding and exercisable, March 31, 2023	4,479,947	$	6.66

Treasury Shares

The Company maintains treasury stock for the Common Stock shares bought back by the Company when withholding shares to cover taxes on transactions related to equity awards. There were no treasury stock transactions during the three months ended March 31, 2023 or the year ended December 31, 2022.

Note 7 - Preferred Stock

Our Certificate of Incorporation authorizes the issuance of up to 5,000,000 shares of preferred stock. As of March 31, 2023, we had 1,983,250 designated shares of preferred stock and 6,550 shares of preferred stock issued and outstanding. As of December 31, 2022, we had no shares of preferred stock outstanding.

Series F Preferred Stock

As described in Note 2, on March 31, 2023, the Company closed a Private Placement and issued (i) 6,550 shares of our newly designated Series F Preferred Stock and (ii) Preferred Warrants to acquire 32,750 shares of Series F Preferred Stock.

As of March 31, 2023, the Company recorded net proceeds from the Private Placement of $1,473,000 to stockholders’ equity. The net proceeds included $6,386,000 in gross proceeds, less (i) $4,000,000 that is being held in escrow and (ii) $913,000 in financing costs.

-11-

The Series F Preferred Shares are convertible into fully paid and non-assessable shares of the Company’s Common Stock at the election of the holder at any time at an initial conversion price of $1.71 (the “Conversion Price”). The holders of the Series F Preferred Shares may also elect to convert their shares at an alternative conversion price equal to the lower of (i) 80% of the applicable Conversion Price as in effect on the date of the conversion, (ii) 80% of the closing price on the trading day immediately preceding the delivery of the conversion notice, and (iii) the greater of (a) the Floor Price (as defined in the Certificate of Designations) and (b) the quotient of (x) the sum of the five lowest Closing Bid Prices (as defined in the Certificate of Designations) for trading days in the 30 consecutive trading day period ending and including the trading day immediately preceding the delivery of the applicable Conversion Notice, divided by (y) five, provided that that such price may not be lower than the Minimum Price (as defined under the Nasdaq Rules) prior to obtaining Stockholder Approval for the issuance. The Conversion Price is subject to customary adjustments for stock splits, stock dividends, stock combination recapitalization, or other similar transactions involving the Common Stock, and subject to price-based adjustment, on a full ratchet basis, in the event of any issuances of our common stock, or securities convertible, exercisable or exchangeable for Common Stock, at a price below the then-applicable Conversion Price (subject to certain exceptions).

Under the Certificate of Designations, the Series F Preferred Shares have an initial stated value of $1,000 per share (the “Stated Value”). The holders of the Series F Preferred Shares are entitled to dividends of 9% per annum, which will be payable in arrears quarterly. Accrued dividends may be paid, at our option, in cash and if not paid, shall increase the stated value of the Series F Preferred Shares. Upon the occurrence and during the continuance of a Triggering Event (as defined in the Certificate of Designations), the Series F Preferred Shares will accrue dividends at the rate of 20% per annum (the “Default Rate”). The Series F Preferred Shares have no voting rights, other than with respect to certain matters affecting the rights of the Series F Preferred Shares. On matters with respect to which the holders of the Series F Preferred Shares have a right to vote, holders of the Preferred Shares will have voting rights on an as-converted basis, provided that until receipt of Stockholder Approval, any adjustment to the Conversion Price shall not cause the Conversion Price for voting purposes to be less than the Minimum Price (as defined in Nasdaq Listing Rule 5635(d)).

Our ability to settle conversions is subject to certain limitations set forth in the Certificate of Designations, including a limit on the number of shares of Common Stock that may be issued until the time that the Stockholder Approval is obtained permitting the issuance of more than 19.99% of our outstanding shares of Common Stock in accordance with Nasdaq listing standards. We agreed to seek Stockholder Approval of these matters at a meeting to be held no later than May 31, 2023. Further, the Certificate of Designations contains a certain beneficial ownership limitation after giving effect to the issuance of shares of common stock issuable upon conversion of the Series F Preferred Shares.

The Certificate of Designations includes certain Triggering Events (as defined in the Certificate of Designations), including, among other things, (i) the failure to file and maintain an effective registration statement covering the sale of the holder’s securities registrable pursuant to the Registration Rights Agreement, (ii) the failure to pay any amounts due to the holders of the Series F Preferred Shares when due, and (iii) if Peter Holst ceases to be the chief executive officer of the Company other than because of his death, and a qualified replacement, reasonably acceptable to a majority of the holders of the Series F Preferred Shares, is not appointed within thirty (30) business days. In connection with a Triggering Event, the Default Rate is triggered. The Default Rate is also triggered in the event that we are unable, from the failure to obtain the Stockholder Approval prior to May 31, 2023 (the “Approval Date”), to issue shares of Common Stock in connection with a conversion of the Series F Preferred Stock after the Approval Date. We are subject to certain affirmative and negative covenants regarding the incurrence of indebtedness, acquisition transactions, the existence of liens, the repayment of indebtedness, the payment of cash in respect of dividends (other than dividends pursuant to the Certificate of Designations), maintenance of properties and the transfer of assets, among other matters.

Series F Preferred Stock Warrants

The Preferred Warrants are exercisable for Series F Preferred Shares at an exercise price of $975. The exercise price is subject to customary adjustments for stock splits, stock dividends, stock combination recapitalizations or other similar transactions involving the Common Stock. The Preferred Warrants expire three years from the date of issuance and are exercisable for cash. For each Preferred Warrant exercised, the Investors shall receive Common Warrants to purchase a number of shares of Common Stock equal to 100% of the number of shares of Common Stock the Investors would receive if the Series F Preferred Shares issuable upon exercise of such Warrant were converted at the applicable Conversion Price. The fair value of the Preferred Warrants was recorded within additional paid-in capital during the three months ended March 31, 2023.

-12-

Note 8 - Stock Based Compensation

On January 3, 2023, the Company effected a 1-for-15 reverse stock split for its Common Stock. All Common Stock share information in the following net loss per share discussion and tables are shown as adjusted for this stock split retrospectively for all periods represented herein.

2019 Equity Incentive Plan

On December 19, 2019, the Oblong, Inc. 2019 Equity Incentive Plan (the “2019 Plan”) was approved by the Company’s stockholders at the Company’s 2019 Annual Meeting of Stockholders. The 2019 Plan is an omnibus equity incentive plan pursuant to which the Company may grant equity and cash incentive awards to certain key service providers of the Company and its subsidiaries. As of March 31, 2023, the share pool available for new grants under the 2019 Plan is 177,567. On April 18, 2023, 177,564 restricted stock units were granted to certain members of the board, reducing the share pool available for new grants under the 2019 Plan to 3.

Stock Options

During the three months ended March 31, 2023 and 2022, no stock options were granted and 6,501 and 334 vested stock options expired, respectively. During the three months ended March 31, 2022, 10,000 unvested stock options were forfeited.

A summary of stock options granted, expired, and forfeited under our plans, and options outstanding as of, and changes made during the three months ended March 31, 2023 and year ended December 31, 2022 is presented below:

	Outstanding			Exercisable
	Number of Options	Weighted Average Exercise Price		Number of Options	Weighted Average Exercise Price
Options outstanding and exercisable, December 31, 2021	27,169	$	113.63	7,169	$	—
Vested	—	—		3,332	48.75
Expired	(501)	410.18		(501)	410.18
Forfeited	(10,000)	48.75		—	—
Options outstanding and exercisable, December 31, 2022	16,668	143.63		10,000	206.85
Expired	(6,501)	289.77		(6,501)	289.77
Options outstanding and exercisable, March 31, 2023	10,167	$	50.17	3,499	$	52.87

Additional information as of March 31, 2023 is as follows:

	Outstanding				Exercisable
Range of price	Number of Options	Weighted Average Remaining Contractual Life (In Years)	Weighted Average Exercise Price		Number of Options	Weighted Average Exercise Price
$0.00 – $100.00	10,000	8.25	$	48.75	3,332	$	48.75
$100.01 – $200.00	167	0.25	135.00		167	135.00
	10,167	8.12	$	50.17	3,499	$	52.87

The intrinsic value of vested and unvested options was not significant for all periods presented. Stock compensation expense, related to stock options, for the three months ended March 31, 2023 was $31,000. Net stock compensation expense, related to stock options, was a negative $32,000, made up of $52,000 in expense offset by $84,000 related to forfeiture credits, for the three months ended March 31, 2022. The remaining unrecognized stock-based compensation expense for options as of March 31, 2023 is $154,000, which will be recognized over a weighted average period of 1.25 years.

-13-

Restricted Stock Awards

As of March 31, 2023, there were 42 unvested restricted stock awards outstanding, with a weighted average grant date price of $235.87. The awards were issued in 2014 and vest over the lesser of ten years, a change in control, or separation from the company. Due to the variability of the vesting, the expense was amortized over an average service period of five years, therefore, there is no unrecognized stock-based compensation expense for restricted stock awards as of March 31, 2023.

Restricted Stock Units

As of March 31, 2023, there were no unvested restricted stock units (“RSUs”) outstanding. As of March 31, 2023, 1,929 vested RSUs remain outstanding as shares of common stock have not yet been delivered for these units in accordance with the terms of the RSUs.

There was no stock compensation expense related to RSUs for the three months ended March 31, 2023 and 2022. There was no remaining unrecognized stock-based compensation expense for RSUs as of March 31, 2023.

On April 18, 2023, 177,564 RSUs were granted to certain board members. These RSUs vested immediately upon issuance.

Note 9 - Net Loss Per Share

On January 3, 2023, the Company effected a 1-for-15 reverse stock split for its Common Stock. All Common Stock share information in the following net loss per share discussion and tables are shown as adjusted for this stock split retrospectively for all periods represented herein.

Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. The weighted-average number of shares of common stock outstanding does not include any potentially dilutive securities or unvested restricted stock. Unvested restricted stock, although classified as issued and outstanding at March 31, 2023 and 2022, is considered contingently returnable until the restrictions lapse and will not be included in the basic net loss per share calculation until the shares are vested. Unvested restricted stock does not contain non-forfeitable rights to dividends and dividend equivalents. Unvested RSUs are not included in calculations of basic net loss per share, as they are not considered issued and outstanding at time of grant.

Diluted net loss per share is computed by giving effect to all potential shares of common stock, including stock options, preferred stock, RSUs, and unvested restricted stock, to the extent they are dilutive. For the three months ended March 31, 2023 and 2022, all such common stock equivalents have been excluded from diluted net loss per share as the effect to net loss per share would be anti-dilutive (due to the net loss).

The following table sets forth the computation of the Company’s basic and diluted net loss per share (in thousands, except per share data):

	Three Months Ended March 31,
	2023		2022
Numerator:
Net loss	$	(1,219)	$	(4,539)
Less: warrant modification	$	(25)	$	—
Net loss attributable to common stockholders	$	(1,244)	$	(4,539)
Denominator:
Weighted-average number of shares of common stock for basic and diluted net loss per share	2,065		2,065
Basic and diluted net loss per share	$	(0.60)	$	(2.20)

The following table represents the potential shares that were excluded from the computation of weighted-average number of shares of common stock in computing the diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect (due to the net loss):

-14-

	Three Months Ended March 31,
	2023	2022
Unvested restricted stock awards	42	42
Outstanding stock options	10,167	16,835
Common stock issuable upon conversion of Series F Preferred Stock	3,830,409	—
Warrants	4,479,947	343,101

Note 10 - Segment Reporting

The Company currently operates in two segments: (1) “Managed Services”, which represents the business surrounding managed services for video collaboration and network applications; and (2) “Collaboration Products” which represents the business surrounding our Mezzanine™ product offerings.

Certain information concerning the Company’s segments for the three months ended March 31, 2023 and 2022 is presented in the following tables (in thousands):

	Three Months Ended March 31, 2023
	Managed Services			Collaboration Products			Corporate		Total
Revenue	$	690		$	348		$	—	$	1,038
Cost of revenues	460			302			—		762
Gross profit	$	230		$	46		$	—	$	276
Gross profit %	33		%	13		%			27		%
Allocated operating expenses	$	—		$	286		$	—	$	286
Unallocated operating expenses	—			—			1,193		1,193
Total operating expenses	$	—		$	286		$	1,193	$	1,479
Income (loss) from operations	$	230		$	(240)		$	(1,193)	$	(1,203)
Interest and other expense (income), net	3			(25)			—		(22)
Net income (loss) before tax	233			(215)			(1,193)		(1,181)
Income tax expense	7			31			—		38
Net income (loss)	$	226		$	(246)		$	(1,193)	$	(1,219)

-15-

	Three Months Ended March 31, 2022
	Managed Services			Collaboration Products			Corporate		Total
Revenue	$	966		$	566		$	—	$	1,532
Cost of revenues	645			388			—		1,033
Gross profit	$	321		$	178		$	—	$	499
Gross profit %	33		%	31		%			33		%
Allocated operating expenses	$	56		$	3,425		$	—	$	3,481
Unallocated operating expenses	—			—			1,540		1,540
Total operating expenses	$	56		$	3,425		$	1,540	$	5,021
Income (loss) from operations	$	265		$	(3,247)		$	(1,540)	$	(4,522)
Interest and other expense (income), net	6			—			—		6
Income (loss) before income taxes	271			(3,247)			(1,540)		(4,528)
Income tax expense	9			2			—		11
Net income (loss)	$	262		$	(3,249)		$	(1,540)	$	(4,539)

Unallocated operating expenses in Corporate include costs for the three months ended March 31, 2023 and 2022 that are not specific to a particular segment but are general to the group; included are expenses incurred for administrative and accounting staff, general liability and other insurance, professional fees and other similar corporate expenses.

For the three months ended March 31, 2023, there was no material revenue attributable to any individual foreign country. For three months ended March 31, 2022, approximately 12% of revenue was attributable to the United Kingdom.

Revenue by geographic area is allocated as follows (in thousands):

	Three Months Ended March 31,
	2023		2022
Domestic	$	563	$	843
Foreign	475		689
	$	1,038	$	1,532

Disaggregated information for the Company’s revenue has been recognized in the accompanying Condensed Consolidated Statements of Operations and is presented below according to contract type (in thousands):

-16-

	Three Months Ended March 31,
	2023		% of Revenue		2022		% of Revenue
Revenue: Managed Services
Video collaboration services	$	64	6	%	$	116	7	%
Network services	618		60	%	821		54	%
Professional and other services	8		1	%	29		2	%
Total Managed Services revenue	$	690	67	%	$	966	63	%
Revenue: Collaboration Products
Visual collaboration product offerings	$	348	33	%	$	562	37	%
Licensing	—		—	%	4		—	%
Total Collaboration Products revenue	348		33	%	566		37	%
Total revenue	$	1,038	100	%	$	1,532	100	%

The Company considers a significant customer to be one that comprises more than 10% of the Company’s consolidated revenues or accounts receivable. The loss of or a reduction in sales or anticipated sales to our most significant or several of our smaller customers could have a material adverse effect on our business, financial condition and results of operations.

Concentration of revenues was as follows:

		Three Months Ended March 31,
		2023		2022
	Segment	% of Revenue		% of Revenue
Customer A	Managed Services	52	%	44	%

Concentration of accounts receivable was as follows:

		As of March 31, 2023
		2023		2022
	Segment	% of Accounts Receivable		% of Accounts Receivable
Customer A	Managed Services	41	%	38	%
Customer B	Managed Services	11	%	—	%
Customer C	Collaboration Products	14	%	—	%
Customer D	Collaboration Products	15	%	—	%
Customer E	Collaboration Products	—	%	13	%
Customer F	Collaboration Products	—	%	10	%

Note 11 - Commitments and Contingencies

From time to time, we are subject to various legal proceedings arising in the ordinary course of business, including proceedings for which we have insurance coverage. As of the date hereof, we are not party to any legal proceedings that we currently believe will have a material adverse effect on our business, financial position, results of operations or liquidity.

COVID-19

On March 11, 2020, the World Health Organization (“WHO”) announced that infections of the novel Coronavirus (COVID-19) had become pandemic, and on March 13, 2020, the U.S. President announced a National Emergency relating to the disease. In May 2023, the WHO declared COVID-19 over as a global health emergency. Customers generally use our Mezzanine™ products in traditional office and operating center environments such as conference rooms or other presentation

-17-

spaces. Revenue declines for our Collaboration Products business are primarily attributable to the aftermath of the COVID-19 pandemic on our existing and target customers as they continue to evaluate behavioral changes in how and when employees choose to work from traditional office environments, resulting in delayed buying decisions for our Collaboration Products. Continuation of the ongoing effects of the COVID-19 pandemic, could cause further disruptions to our operations and the operations of our customers, suppliers and logistics partners and could significantly adversely affect our near-term and long-term revenues, earnings, liquidity and cash flows.

-18-

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Overview

We are a provider of patented multi-stream collaboration products and managed services for video collaboration and network solutions.

Mezzanine™ Product Offerings

Our flagship product is called Mezzanine™, a family of turn-key products that enable dynamic and immersive visual collaboration across multi-users, multi-screens, multi-devices, and multi-locations (see further description of Mezzanine™ in Part I, Item 1). Mezzanine™ allows multiple people to share, control and arrange content simultaneously, from any location, enabling all participants to see the same content in its entirety at the same time in identical formats, resulting in dramatic enhancements to both in-room and virtual videoconference presentations. Applications include video telepresence, laptop and application sharing, whiteboard sharing and slides. Spatial input allows content to be spread across screens, spanning different walls, scalable to an arbitrary number of displays and interaction with our proprietary wand device. Mezzanine™ substantially enhances day-to-day virtual meetings with technology that accelerates decision making, improves communication, and increases productivity. Mezzanine™ scales up to support the most immersive and commanding innovation centers; across to link labs, conference spaces, and situation rooms; and down for the smallest work groups. Mezzanine’s digital collaboration platform can be sold as delivered systems in various configurations for small teams to total immersion experiences. The family includes the 200 Series (two display screen), 300 Series (three screen), and 600 Series (six screen). We also sell maintenance and support contracts related to Mezzanine™.

Historically, customers have used Mezzanine™ products in traditional office and operating center environments such as conference rooms or other presentation spaces. As discussed below, sales of our Mezzanine product have been adversely affected by commercial response to the COVID-19 pandemic. Like many technology companies in recent months, we will continue to monitor and manage our costs relative to demand with the goal of growing the Company’s revenue in the future. To the extent we believe new investments in product development, marketing, or sales are warranted as a result of changes in market demand, we believe additional capital will be required to fund those efforts and our ongoing operations.

Managed Services for Video Collaboration

We provide a range of managed services for video collaboration, from automated to orchestrated, to simplify the user experience in an effort to drive adoption of video collaboration throughout our customers’ enterprise. We deliver our services through a hybrid service platform or as a service layer on top of our customers’ video infrastructure. We provide our customers with i) managed videoconferencing, where we set up and manage customer videoconferences and ii) remote service management, where we provide 24/7 support and management of customer video environments.

Managed Services for Network

We provide our customers with network solutions that ensure reliable, high-quality and secure traffic of video, data and internet. Network services are offered to our customers on a subscription basis. Our network services business carries variable costs associated with the purchasing and reselling of this connectivity.

Oblong’s Results of Operations

Three Months Ended March 31, 2023 (the “2023 First Quarter”) compared to the Three Months Ended March 31, 2022 (the “2022 First Quarter”)

Segment Reporting

The Company currently operates in two segments: (1) “Collaboration Products,” which represents the business surrounding our Mezzanine™ product offerings, and (2) “Managed Services,” which represents the business surrounding managed services for video collaboration and network solutions. Certain information concerning the Company’s segments for the three months ended March 31, 2023 and 2022 and is presented below (in thousands):

-19-

	Three Months Ended March 31, 2023
	Managed Services			Collaboration Products			Corporate		Total
Revenue	$	690		$	348		$	—	$	1,038
Cost of revenues	460			302			—		762
Gross profit	$	230		$	46		$	—	$	276
Gross profit %	33		%	13		%			27		%
Allocated operating expenses	$	—		$	286		$	—	$	286
Unallocated operating expenses	—			—			1,193		1,193
Total operating expenses	$	—		$	286		$	1,193	$	1,479
Income (loss) from operations	$	230		$	(240)		$	(1,193)	$	(1,203)
Interest and other expense (income), net	3			(25)			—		(22)
Net income (loss) before tax	233			(215)			(1,193)		(1,181)
Income tax expense	7			31			—		38
Net income (loss)	$	226		$	(246)		$	(1,193)	$	(1,219)

	Three Months Ended March 31, 2022
	Managed Services			Collaboration Products			Corporate		Total
Revenue	$	966		$	566		$	—	$	1,532
Cost of revenues	645			388			—		1,033
Gross profit	$	321		$	178		$	—	$	499
Gross profit %	33		%	31		%			33		%
Allocated operating expenses	$	56		$	3,425		$	—	$	3,481
Unallocated operating expenses	—			—			1,540		1,540
Total operating expenses	$	56		$	3,425		$	1,540	$	5,021
Income (loss) from operations	$	265		$	(3,247)		$	(1,540)	$	(4,522)
Interest and other expense (income), net	6			—			—		6
Income (loss) before income taxes	271			(3,247)			(1,540)		(4,528)
Income tax expense	9			2			—		11
Net income (loss)	$	262		$	(3,249)		$	(1,540)	$	(4,539)

Unallocated operating expenses in Corporate include costs during the 2023 First Quarter that are not specific to a particular segment but are general to the group; included are expenses incurred for administrative and accounting staff, general liability and other insurance, professional fees and other similar corporate expenses.

Revenue. Total revenue decreased 32% in the 2023 First Quarter compared to the 2022 First Quarter. The following table summarizes the changes in components of our revenue (in thousands), and the significant changes in revenue are discussed in more detail below.

-20-

	Three Months Ended March 31,
	2023		% of Revenue		2022		% of Revenue
Revenue: Managed Services
Video collaboration services	$	64	6	%	$	116	7	%
Network services	618		60	%	821		54	%
Professional and other services	8		1	%	29		2	%
Total Managed Services revenue	$	690	67	%	$	966	63	%
Revenue: Collaboration Products
Visual collaboration product offerings	$	348	33	%	$	562	37	%
Licensing	—		—	%	4		—	%
Total Collaboration Products revenue	348		33	%	566		37	%
Total revenue	$	1,038	100	%	$	1,532	100	%

Managed Services

•The decrease in revenue for video collaboration services is mainly attributable to lower revenue from existing customers (either from reductions in price or level of services) and loss of customers to competition.

•The decrease in revenue for network services is mainly attributable to net attrition of customers and lower demand for our services given the competitive environment and pressure on pricing that exists in the network services business.

•We expect revenue declines in our Managed Services segment will continue in the future.

Collaboration Products

•Customers generally use our Mezzanine™ products in traditional office and operating center environments such as conference rooms or other presentation spaces. The year over year decrease in revenue for our Collaboration Products business is primarily attributable to the aftermath of the COVID-19 pandemic on our existing and target customers as they continue to evaluate behavioral changes in how and when employees choose to work from traditional office environments, resulting in delayed buying decisions for our Collaboration Products. Continuation of the ongoing effects of the COVID-19 pandemic, could cause further disruptions to our operations and the operations of our customers, suppliers and logistics partners and could significantly adversely affect our near-term and long-term revenues, earnings, liquidity and cash flows.

Cost of Revenue (exclusive of depreciation and amortization). Cost of revenue, exclusive of depreciation and amortization and casualty loss, includes all internal and external costs related to the delivery of revenue. Cost of revenue also includes taxes which have been billed to customers. Cost of revenue by segment is presented in the following table (in thousands):

	Three Months Ended March 31,
	2023		2022
Cost of Revenue
Managed Services	$	460	$	645
Collaboration Products	302		388
Total cost of revenue	$	762	$	1,033

The decrease in our consolidated cost of revenue is mainly attributable to lower costs associated with the decrease in revenue during the same period. Our consolidated gross profit as a percentage of revenue was 27% in the 2023 First Quarter compared to 33% in the 2022 First Quarter. The gross profit as a percentage of revenue for our Collaboration Products segment was 13% in the 2023 First Quarter compared to 31% in the 2022 First Quarter. This decrease was mainly attributable to i) an increase in our inventory obsolescence reserve of $26,000 in the 2023 First Quarter as compared to the 2022 First Quarter, ii) a

-21-

one-time assessment for common area charges on warehouse space of $12,000, and iii) an increase in personnel costs as a percentage of revenue between these periods.

Operating expenses are presented in the following table (in thousands):

	Three Months Ended March 31,
	2023		2022		$ Change		% Change
Operating expenses:
Research and development	$	6	$	1,004	$	(998)	(99)	%
Sales and marketing	218		562		(344)		(61)	%
General and administrative	1,169		1,690		(521)		(31)	%
Impairment charges	—		1,138		(1,138)		(100)	%
Depreciation and amortization	86		627		(541)		(86)	%
Total operating expenses	$	1,479	$	5,021	$	(3,542)	(71)	%

Research and Development. Research and development expenses include internal and external costs related to developing new product offerings as well as features and enhancements to our existing product offerings. The decrease in research and development expenses for the 2023 First Quarter compared to the 2022 First Quarter is primarily attributable to the shut down of R&D expenses at the end of the 2022 First Quarter, in order to conserve cash, which resulted in lower personnel costs due to reduced headcount, consulting, and outsourced labor costs between these periods.

Sales and Marketing Expenses. The decrease in sales and marketing expenses for 2023 First Quarter compared to the 2022 First Quarter is primarily attributable to lower personnel costs due to reduced headcount, reduced marketing costs between these periods, and lower sales as discussed above.

General and Administrative Expenses. General and administrative expenses include direct corporate expenses and costs of personnel in the various corporate support categories, including executive, finance and accounting, legal, human resources and information technology. The decrease in general and administrative expenses for the 2023 First Quarter compared to the 2022 First Quarter is primarily attributable to a decrease in office related expenses and professional services.

Impairment Charges. There were no impairment charges in the 2023 First Quarter. The impairment charges in the 2022 First Quarter were attributable to goodwill. Future declines of our revenue, cash flows and/or market capitalization may give rise to a triggering event that may require the Company to record impairment charges in the future related to our intangible assets and other long-lived assets.

Depreciation and Amortization. The decrease in depreciation and amortization expenses for the 2023 First Quarter compared to the 2022 First Quarter is mainly attributable to the disposition and impairment of certain assets during the year ended 2022, as well as a decrease in depreciation as certain assets became fully depreciated.

Loss from Operations. The decrease in the Company’s loss from operations for the 2023 First Quarter compared to the 2022 First Quarter is mainly attributable to lower operating expenses as addressed above.

Off-Balance Sheet Arrangements

As of March 31, 2023, we had no off-balance sheet arrangements.

Inflation

Management does not believe inflation had a significant effect on the Condensed Consolidated Financial Statements for the periods presented.

Critical Accounting Policies

There have been no changes to our critical accounting policies during the three months ended March 31, 2023. Critical accounting policies and the significant estimates made in accordance with such policies are regularly discussed with our Audit

-22-

Committee. Those policies are discussed under “Critical Accounting Policies” in “Part II. Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” as well as in our Condensed Consolidated Financial Statements and the footnotes thereto, each included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the SEC on March 21, 2023 (the “2022 Annual Report”).

Liquidity and Capital Resources

As of March 31, 2023, we had $3,714,000 in cash and working capital of $3,335,000. For the three months ended March 31, 2023, we incurred a net loss of $1,219,000 and used $844,000 of net cash in operating activities.

Equity Private Placement

On March 30, 2023, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which we issued and sold, in a private placement transaction (the “Private Placement”), (i) 6,550 shares (the “Preferred Shares”) of our newly designated Series F convertible preferred stock, $0.0001 par value per share (the “Series F Preferred Stock”), initially convertible into up to 3,830,409 shares of our Common Stock, (ii) preferred warrants (“Preferred Warrants”) to acquire 32,750 shares of Series F Preferred Stock, and (iii) common warrants (“Common Warrants” and with the Preferred Warrants, the “Investor Warrants”) to acquire up to 3,830,413 shares of Common Stock. The terms of the Series F Preferred Stock are as set forward in the Certificate of Designations of Series F Preferred Stock of Oblong, Inc. (the “Certificate of Designations”), which was filed and became effective with the Secretary of State of the State of Delaware on March 31, 2023. The Private Placement closed on March 31, 2023. Please see the discussion in Note 6 - Capital Stock for further details on the Common Warrants and Note 7 - Preferred Stock for further discussion on the Series F Preferred Stock and Preferred Warrants.

The aggregate gross proceeds of the Private Placement are expected to be $6,386,250. All of the Preferred Shares and warrants were issued at the Closing, but part of the purchase price equivalent to $4,000,000 was placed into an escrow account with American Stock Transfer & Trust Company (the “Escrow”), to be released upon our obtaining stockholder approval permitting the issuance of more than 19.99% of our outstanding shares of Common Stock at less than the Minimum Price (as defined under the Nasdaq Rules) in accordance with Nasdaq listing standards and as otherwise may be required (the “Stockholder Approval”). The Company expects to use the net proceeds from the Private Placement and the proceeds, if any, from the exercise of the Investor Warrants for general corporate purposes and potential strategic alternatives. We have not, no has anyone on our behalf, initiated any substantive discussions directly or indirectly with any strategic alternatives partner.

In connection with the Private Placement, pursuant to an engagement letter dated March 30, 2023 (the “Engagement Letter”), between the Company and Dawson James Securities, Inc. (the “Placement Agent”), the Company agreed to (i) pay the Placement Agent a cash fee equal to 8% of the aggregate gross proceeds raised in the Private Placement, and (ii) grant to the Placement Agent warrants (the “Placement Agent Warrants”) to purchase 306,433 shares of Common Stock at an initial exercise price of $1.71 per share. Additionally, we agreed to reimburse the Placement Agent for certain expenses incurred in connection with the Private Placement and to pay certain contingent fees upon the occurrence of specified future events. Please see the discussion in Note 6 - Capital Stock for further details on the Placement Agent Warrants.

Future Capital Requirements and Going Concern

Our capital requirements in the future will continue to depend on numerous factors, including the potential release of the Escrow, the amount of revenue the Company is able to generate, customer renewal rates and the timing of collection of outstanding accounts receivable, in each case particularly as it relates to the Company’s major customers, the expense to deliver services, expense for sales and marketing, and expense for research and development. The Company believes that, in the event the Escrow is not released, based on its current projection of revenue, expenses, and cash flows, it will not have sufficient resources to fund its operations for the next twelve months following the filing of this Report. We believe additional capital will be required, in the short-term and the long-term, to fund operations and provide growth capital including investments in technology, product development and sales and marketing. To access capital to fund operations or provide growth capital, we will need to raise capital in one or more debt and/or equity offerings. There can be no assurance that we will be successful in raising necessary capital or that any such offering will be on terms acceptable to the Company. If we are unable to raise additional capital that may be needed on terms acceptable to us, it could have a material adverse effect on the Company. The factors discussed above raise substantial doubt as to our ability to continue as a going concern. The accompanying Consolidated Financial Statements do not include any adjustments that might result from these uncertainties.

-23-

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a “smaller reporting company” as defined by the rules and regulations of the SEC, we are not required to provide this information.

ITEM 4. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) as of March 31, 2023. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of March 31, 2023, the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the SEC’s rules and forms and are designed to ensure that information required to be disclosed by the Company in the reports we file or submit under the Exchange Act is accumulated and communicated to the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

No change in our internal control over financial reporting occurred during the fiscal quarter ended March 31, 2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

From time to time, we are subject to various legal proceedings arising in the ordinary course of business, including proceedings for which we have insurance coverage. As of the date hereof, we are not party to any legal proceedings that we currently believe will have a material adverse effect on our business, financial position, results of operations or liquidity.

ITEM 1A. RISK FACTORS

A description of the risks associated with our business, financial conditions and results of operations is set forth in “Part I. Item 1A. Risk Factors” of our 2022 Annual Report. Except as set forth below, there have been no material changes to these risks during the three months ended March 31, 2023. The risks described in the 2022 Annual Report are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or future results.

The terms of the Series F Preferred Stock could limit our growth and our ability to finance our operations, fund our capital needs, respond to changing conditions and engage in other business activities that may be in our best interests. The Certificate of Designations for the Series F Preferred Stock contains a number of affirmative and negative covenants regarding matters such as the payment of dividends, maintenance of our properties and assets, transactions with affiliates, and our ability to issue other indebtedness. No assurances can be given that we will be able to comply with the financial or other covenants contained in the Certificate of Designations. If we are unable to comply with certain terms in the Certificate of Designations:

• dividends will accrue on the Series B Preferred Stock at 20% per annum;

• the holders of the Series B Preferred Stock could foreclose against our assets; and/or

• we could be forced into bankruptcy or liquidation.

Our ability to comply with these covenants may be adversely affected by events beyond our control, and we cannot assure you that we can maintain compliance with these covenants. The financial covenants could limit our ability to make needed expenditures or otherwise conduct necessary or desirable business activities.

The issuance of the securities in the Private Placement significantly diluted the ownership interest of the existing holders of our common stock, and the market price of our common stock will likely decline significantly as a result of sales of such securities into the public market by the Investors and subsequent investors or the perception that such sales may

-24-

occur. Our existing holders of common stock have been significantly diluted by the issuance of the securities in the Private Placement. Our public float was significantly increased and the market price of our common stock could decline significantly as a result of subsequent sales of the shares of common stock issued in the Private Placement, or the perception that such sales may occur.

In addition, the exercise price or conversion price of these securities may be at prices below the current and/or then trading prices of shares of our common stock or at prices below the price at which our existing shareholders purchased our common stock. The Investors may potentially make a significant profit with the resale of the securities depending on the trading price of our securities at the time of a sale and the purchase price of such securities by them. While the Investors may experience a positive rate of return based on the trading price of our securities, the existing holders of our common stock may not experience a similar rate of return on the shares of common stock they purchased due to differences in the applicable purchase price and trading price.

If our stockholders do not approve the issuance by us in the Private Placement of more than 19.99% of our outstanding shares of Common Stock at less than the Minimum Price (as defined under the Nasdaq listing rules), our ability to finance our operations, execute our business plan and fund our capital needs will be materially and adversely affected. All of the Preferred Shares and Investor Warrants were issued at the closing of the Private Placement, but part of the purchase price equivalent to $4 million has been placed in an escrow account until the Stockholder Approval is obtained. Effectively, stockholder approval is one of the conditions for us to receive (i) $4 million in escrow and (ii) approximately $31.9 million upon the exercise of the Preferred Warrants, if exercised for cash. If the Stockholder Approval is not obtained, we will not be able to access such funds and our ability to execute our business plan will be jeopardized and we will be materially and adversely affected.

The failure of our stockholders to approve this proposal will mean that the conversion of the Preferred Shares and the exercise of the Common Warrants will be limited to the extent that such conversion or exercise, together with any other securities convertible or exchangeable for shares, would result in the issuance, in the aggregate, of no more than 19.99% of the shares of our Common Stock outstanding. As a result, we may be unable to issue sufficient shares upon conversion of the Preferred Shares or exercise of the Warrants which will, in lieu of those shares, require that we pay buy-in cash amounts to the Investors. We do not anticipate having sufficient funds to make any substantial cash payments to the holders of the Preferred Shares.

Our ability to successfully implement our business plan and ultimately generate value for our stockholders is dependent upon our ability to raise capital and satisfy our ongoing business needs. If we are required to satisfy our buy-in payment obligations in cash rather than Common Stock, we may not have the capital necessary to fully satisfy our ongoing business needs, the effect of which would adversely impact future operating results, and result in a delay in our business plans. Additionally, it may be necessary for the Company to obtain additional financing in order to pay the obligations in cash, which may result in additional transaction expenses.

Further, pursuant to the terms of the Purchase Agreement, if our stockholders do not approve this proposal, we will be required to seek stockholder approval of this proposal again on or before July 31, 2023, and thereafter semi-annually until we receive stockholder approval of this proposal. As such, our failure to obtain stockholder approval of this proposal at the May 18, 2023 Special Meeting will require us to incur the costs of holding one or more additional stockholder meetings until we receive such approval.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Unregistered Sales of Equity Securities by the Company

There have been no unregistered sales of securities by the Company during the period covered by this Report that have not been previously reported in a Current Report on Form 8-K.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

-25-

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

-26-

ITEM 6. EXHIBITS

Exhibit Number	Description
3.1*	Amended and Restated Certificate of Incorporation, as amended.
4.1	Form of Amendment to Series A Warrants (filed as Exhibit 4.1 to the Registrants Current Report on Form 8-K, filed with the SEC on January 3, 2023, and incorporated herein by reference).
4.2	Certificate of Designations, Preferences and Rights of Series D Preferred Stock (filed as Exhibit 4.6 to the Registrant’s Current Report on Form 8-K filed with the SEC on September 24, 2007, and incorporated herein by reference).
4.3	Certificate of Designations, Preferences and Rights of Series A-2 Preferred Stock of the Registrant (filed as Exhibit 4.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on August 11, 2009, and incorporated herein by reference).
4.4	Certificate of Designations, Preferences and Rights of Perpetual Series B Preferred Stock of the Registrant (filed as Exhibit 4.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on March 30, 2010, and incorporated herein by reference).
4.5	Certificate of Designations, Preferences and Rights of Perpetual Series B-1 Preferred Stock of the Registrant (filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on August 9, 2011, and incorporated herein by reference).
4.6	Certificate of Designations of Rights, Powers, Preferences, Privileges and Restrictions of the 0% Series B Convertible Preferred Stock (filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on November 14, 2017, and incorporated herein by reference).
4.7	Certificate of Designations of Rights, Powers, Preferences, Privileges and Restrictions of the 0% Series C Convertible Preferred Stock (filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on January 25, 2018, and incorporated herein by reference).
4.8	Certificate of Designations of the 6.0% Series D Convertible Preferred Stock (filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on October 7, 2019, and incorporated herein by reference).
4.9	Certificate of Designations of the 6.0% Series E Convertible Preferred Stock (filed as Exhibit 3.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on October 7, 2019, and incorporated herein by reference).
4.10	Certificate of Designations of the 9.0% Series F Convertible Preferred Stock (filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on April 3, 2023, and incorporated herein by reference).
4.11	Form of Common Warrant (filed as Exhibit 4.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on April 3, 2023, and incorporated herein by reference).
4.12	Form of Preferred Warrant (filed as Exhibit 4.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on April 3, 2023, and incorporated herein by reference).
10.1	Securities Purchase Agreement, dated March 31, 2023 (filed as Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on April 3, 2023, and incorporated herein by reference).
10.2	Registration Rights Agreement, dated March 31, 2023 (filed as Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on April 3, 2023, and incorporated herein by reference).
10.3	Engagement Letter, dated March 30, 2023 (filed as Exhibit 10.3 to the Registrant’s Current Report on Form 8-K filed with the SEC on April 3, 2023, and incorporated herein by reference).
10.4	Form of Warrant Repricing Letter, dated April 18, 2023 (filed as Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on April 24, 2023, and incorporated herein by reference).
31.1*	Rule 13a—14(a)/15d—14(a) Certification of the Chief Executive Officer.
31.2*	Rule 13a—14(a)/15d—14(a) Certification of the Chief Financial Officer.
32.1**	Section 1350 Certification of the Chief Executive Officer and Chief Financial Officer.
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema
101.CAL	XBRL Taxonomy Extension Calculation Linkbase
101.DEF	XBRL Taxonomy Extension Definition Linkbase
101.LAB	XBRL Taxonomy Extension Label Linkbase
101.PRE	XBRL Taxonomy Extension Presentation Linkbase

* Filed herewith.

** Furnished herewith.

-27-

SIGNATURES

In accordance with the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.    

	OBLONG, INC.
May 10, 2023	By:	/s/ Peter Holst
		Peter Holst
		Chief Executive Officer
		(Principal Executive Officer)

May 10, 2023	By:	/s/ David Clark
		David Clark
		Chief Financial Officer
		(Principal Financial and Accounting Officer)

-28-

EX-3.1

EXHIBIT 3.1

CONFORMED COPY TO REFLECT AMENDMENTS MADE

THROUGH MARCH 31, 20231

AMENDED AND RESTATED CERTIFICATE OF INCORPORATION

OF

OBLONG, INC.

FIRST:        The name of the Corporation is Oblong, Inc.

SECOND:    The address of its registered office in the State of Delaware is 2711 Centerville Road, Suite 400, in the City of Wilmington, 19808, County of New Castle. The name of its registered agent at such address is Corporation Service Company.

THIRD:    The nature of the business of the Corporation and the objects or purposes to be transacted, promoted or carried on by it are as follows: To engage in any lawful act or activity for which corporations may be organized under the General Corporation Law (the “GCL”) of the State of Delaware.

FOURTH:    The total number of shares of all classes of stock that the Corporation is authorized to issue is one hundred fifty-five million (155,000,000) shares, consisting of one hundred fifty million (150,000,000) shares of Common Stock with a par value of $0.0001 per share and five million (5,000,000) shares of Preferred Stock with a par value of $0.0001 per share.

Upon the effectiveness of this Certificate of Amendment [filed with the Secretary of State of the State of Delaware on January 10, 2011], every four (4) issued and outstanding shares of Common Stock of the Corporation shall be changed and reclassified into one (1) share of Common Stock, which shares shall be fully paid and nonassessable shares of Common Stock of the Corporation; provided, however, that in lieu of fractional interests in shares of Common Stock to which any stockholder would otherwise be entitled pursuant hereto (taking into account all shares of Common Stock owned by such stockholder), any such fractional interests in shares of Common Stock shall be paid in cash in an amount equal to such fraction multiplied by the average of the high and low trading prices of the Corporation’s Common Stock on the OTC Bulletin Board during regular trading hours for the five trading days immediately preceding the effectiveness of this Certificate of Amendment [on January 10, 2011].

Upon the filing and effectiveness (the “[2019] Effective Time”), pursuant to the Delaware General Corporation Law, of this Certificate of Amendment to the Certificate of Incorporation of the Corporation [filed with the Secretary of State of the State of Delaware on April 17, 2019], each ten (10) shares of Common Stock either issued and outstanding or held by the Corporation in treasury stock immediately prior to the [2019] Effective Time shall, automatically and without any action on the part of the respective holders thereof, be combined and converted into one (1) fully paid and nonassessable share of Common Stock (the “[2019] Reverse Stock Split”). No fractional shares shall

1 The original Certificate of Incorporation of Oblong, Inc. (the “Certificate of Incorporation”) was filed with the Secretary of State of the State of Delaware (the “Delaware Secretary”) on November 4, 1996. The Certificate of Incorporation was amended by that certain Agreement and Plan of Merger, dated as of November 27, 1996, and Certificate of Amendment filed with the Delaware Secretary on May 18, 2000, and subsequently amended and restated in its entirety by the Amended and Restated Certificate of Incorporation filed with the Delaware Secretary on May 18, 2000 (such certificate, the “A&R Certificate of Incorporation”). The A&R Certificate of Incorporation was subsequently amended by the Certificate of Amendment, filed with the Delaware Secretary on September 24, 2003, Certificate of Amendment, filed with the Delaware Secretary on August 22, 2007, Certificate of Amendment, filed with the Delaware Secretary on June 2, 2009, Certificate of Amendment, filed with the Delaware Secretary on January 10, 2011, Certificate of Amendment, filed with the Delaware Secretary on April 17, 2019, and Certificate of Amendment, filed with the Delaware Secretary on March 6, 2020, and Certificate of Amendment, filed with the Delaware Secretary on December 30, 2022.

Certain language has been added in brackets for clarification purposes.

See Annex I for Certificates of Designation for the Corporation’s Series of Preferred Stock and Certificates Eliminating Reference to certain Series of Preferred Stock.

be issued in connection with the [2019] Reverse Stock Split. In lieu of any fractional share of Common Stock to which a stockholder would otherwise be entitled in connection with the [2019] Reverse Stock Split (taking into consideration all shares of Common Stock owned by such stockholder), the Corporation will issue that number of shares of Common Stock resulting from the [2019] Reverse Stock Split as rounded up to the nearest whole share upon the submission of a transmission letter by a stockholder holding the shares in book-entry form and, where shares are held in certificated form, upon the surrender of the stockholder’s Old Certificates (as defined below). Each certificate that immediately prior to the [2019] Effective Time represented shares of Common Stock (“[2019] Old Certificates”), shall thereafter represent that number of shares of Common Stock into which the shares of Common Stock represented by the [2019] Old Certificate shall have been combined, subject to the elimination of fractional share interests as described above.

The par value per share of the Corporation’s capital stock and the total number of shares of all classes of capital stock that the Corporation is authorized to issue pursuant to this Article IV shall, in each case, not be affected by the [2019] Reverse Stock Split.

Upon the filing and effectiveness (the “[2023] Effective Time”), pursuant to the Delaware General Corporation Law, of this Certificate of Amendment to the Certificate of Incorporation of the Corporation [filed with the Secretary of State of the State of Delaware on December 30, 2022 and effective on January 3, 2023], each fifteen (15) shares of Common Stock either issued and outstanding or held by the Corporation in treasury stock immediately prior to the [2023] Effective Time, shall, automatically and without any action on the part of the respective holders thereof, be combined and converted into one (1) fully paid and nonassessable share of Common Stock (the “[2023] Reverse Stock Split”). No fractional shares shall be issued in connection with the [2023] Reverse Stock Split. In lieu of any fractional share of Common Stock to which a stockholder would otherwise be entitled in connection with the [2023] Reverse Stock Split (taking into consideration all shares of Common Stock owned by such stockholder), the Corporation will issue that number of shares of Common Stock resulting from the [2023] Reverse Stock Split as rounded up to the nearest whole share upon the submission of a transmission letter by a stockholder holding the shares in book-entry form and, where shares are held in certificated form, upon the surrender of the stockholder’s [2023] Old Certificates (as defined below). Each certificate that immediately prior to the [2023] Effective Time, represented shares of Common Stock (“[2023] Old Certificates”), shall thereafter represent that number of shares of Common Stock into whichthe shares of Common Stock represented by the [2023] Old Certificate shall have been combined, subject to the elimination of fractional share interests as described above in this paragraph.

The par value per share of the Corporation’s capital stock and the total number of shares of all classes of capital stock that the Corporation is authorized to issue pursuant to this Article IV shall, in each case, not be affected by the [2023] Reverse Stock Split.

FIFTH:        The following provisions are inserted for the management of the business and the conduct of the affairs of the Corporation, and for further definition, limitation and regulation of the powers of the Corporation and of its directors and stockholders:

a)The business and affairs of the Corporation shall be managed by or under the direction of the Board of Directors.

b)The directors shall have concurrent power with the stockholders to make, alter, amend, change, add to or repeal the By-Laws of the Corporation.

c)The number of directors of the Corporation shall be as from time to time fixed by, or in the manner provided in, the By-Laws of the Corporation. Election of directors need not be by written ballot unless the By-Laws so provide.

d)No director shall be personally liable to the Corporation or any of its stockholders for monetary damages for breach of fiduciary duty as a director, except for liability (i) for any breach of

2

the director’s duty of loyalty to the Corporation or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) pursuant to Section 174 of the GCL or (iv) for any transaction from which the director derived an improper personal benefit. Any repeal or modification of this Article Seventh by the stockholders of the Corporation shall not adversely affect any right or protection of a director of the Corporation existing at the time of such repeal or modification with respect to acts or omissions occurring prior to such repeal or modification.

e)In addition to the powers and authority hereinbefore or by statute expressly conferred upon them, the directors are hereby empowered to exercise all such powers and do all such acts and things as my be exercised or done by the Corporation, subject, nevertheless, to the provisions of the GCL, this Certificate of Incorporation, and any By-Laws adopted by the stockholders; provided, however, that no By-Laws hereafter adopted by the stockholders shall invalidate any prior act of the directors which would have been valid if such By-Laws had not been adopted.

SIXTH:    Meetings of stockholders may be held within or without the State of Delaware, as the By-Laws may provide. The books of the Corporation my be kept (subject to any provision contained in the GCL) outside the State of Delaware at such place or places as my be designated from time to time by the Board of Directors or in the By-Laws of the Corporation.

SEVENTH:    The Board of Directors shall not be divided into classes. Each director shall be elected to serve a one-year term expiring at the next Annual Meeting of Shareholders and until her or her successor is duly elected and qualified.

EIGHTH:    Whenever a compromise or arrangement is proposed between this Corporation and its creditors or any class of them and/or between this Corporation and its stockholders of any class of them, any court of equitable jurisdiction within the State of Delaware may, on the application in a summary way of this Corporation or any creditor or stockholder thereof, or on the application of any receiver or receivers appointed for this Corporation under the provisions of Section 291 of Title 8 of the Delaware Code or on the application of trustees in dissolution or of any receiver or receivers appointed for this Corporation under the provisions of Section 279 of Title 8 of the Delaware Code order a meeting of the creditors or class of creditors, and/or of the stockholders or class of stockholders of this Corporation, as the case may be, to be summoned in such manner as the said court directs. If a majority in number representing three-fourths in value of the creditors or class of creditors, and/or of the stockholders or class of stockholders of this Corporation, as the case may be, agree to any compromise or arrangement and to any reorganization of this Corporation as a consequence of such compromise or arrangement, the said compromise or arrangement and the said reorganization shall, if sanctioned by the court to which the said application has been made, be binding on all the creditors or class of creditors, and/or on all the stockholders or class of stockholders, of this Corporation, as the case may be, and also on this Corporation.

NINTH:    The Corporation reserves the right to amend, alter, change or repeal any provision contained in this Certificate of Incorporation, in the manner now or hereafter prescribed by statute, and all rights conferred upon stockholders herein are granted subject to this reservation.

3

ANNEX I

Certificates of Designation and Certificates Eliminating Reference

The Corporation has filed the following Certificates of Designation, Preferences and Rights of Preferred Stock and Certificates Eliminating Reference with the Secretary of State of the State of Delaware:

1.Series A Preferred Stock of Wire One Technologies, Inc. filed June 14, 2000;

a.Certificate of Amendment filed June 22, 2001;

b.Certificate Eliminating Reference to Series A Preferred Stock from the Certificate of Incorporation of Glowpoint, Inc. filed December 6, 2007*;

2.Series B Convertible Preferred Stock of Glowpoint, Inc. filed January 22, 2004;

a.Certificate Eliminating Reference to Series B Convertible Preferred Stock from the Certificate of Incorporation of Glowpoint, Inc. filed December6, 2007*;

3.Series C Preferred Stock of Glowpoint, Inc. filed September 21, 2007;

a.Certificate Eliminating Reference to Series C Preferred Stock from the Certificate of Incorporation of Glowpoint, Inc. filed August 6, 2009*;

4.Series D Preferred Stock of Glowpoint, Inc. filed September 21, 2007**;

5.Series A Preferred Stock of Glowpoint, Inc. filed November 25, 2008;

a.Certificate Eliminating Reference to Series A Preferred Stock from the Certificate of Incorporation of Glowpoint, Inc. filed August 6, 2009*;

6.Series A-1 Convertible Preferred Stock of Glowpoint, Inc. filed March 16, 2009;

a.Certificate Eliminating Reference to Series A-1 Convertible Preferred Stock from the Certificate of Incorporation of Glowpoint, Inc. filed April 6, 2010*;

7.Series A-2 Convertible Preferred Stock of Glowpoint, Inc. filed August 10, 2009**;

8.Perpetual Series B Preferred Stock of Glowpoint, Inc. filed March 29, 2010**;

9.Series B-1 Preferred Stock of Glowpoint, Inc. filed August 3, 2011**;

10.0% Series B Convertible Preferred Stock of Glowpoint, Inc. filed October 23, 2017**;

a.a Certificate of Correction to the Certificate of Designation of the 0% Series B Convertible Preferred Stock of Glowpoint. Inc., filed November 9, 2017**;

11.0% Series C Convertible Preferred Stock of Glowpoint, Inc. filed January 22, 2018**;

12.6.0% Series D Convertible Preferred Stock of Glowpoint, Inc. filed October 1, 2019**;

13.6.0% Series E Convertible Preferred Stock of Glowpoint, Inc. filed October 1, 2019**; and

14.Series F Convertible Preferred Stock of Oblong, Inc. filed March 31, 2023**.

* Attached to this Annex I.

** Publicly filed as an exhibit to the Corporation’s filings with the Securities and Exchange Commission.

4

EX-31.1

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

I, Peter Holst, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Oblong, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;  and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 10, 2023

/s/ Peter Holst    

Peter Holst

Chief Executive Officer

(principal executive officer)

EX-31.2

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

I, David Clark, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Oblong, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;  and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 10, 2023

/s/ David Clark    

David Clark

Chief Financial Officer

(principal financial and accounting officer)

EX-32.1

Exhibit 32.1

SECTION 906 CERTIFICATION

The undersigned officers of Oblong, Inc., a Delaware corporation (the "Company"), do hereby certify, in accordance with 18 U.S.C. Section 1350, as created pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.The accompanying Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2023 (the "Report") fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 10, 2023

/s/ Peter Holst    

Peter Holst

Chief Executive Officer

/s/ David Clark    

David Clark

Chief Financial Officer

XML

Cover - shares	3 Months Ended
	Mar. 31, 2023	May 09, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Document Transition Report	false
Entity File Number	001-35376
Entity Registrant Name	OBLONG, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	77-0312442
Entity Address, Address Line One	25587 Conifer Road
Entity Address, Address Line Two	Suite 105-231
Entity Address, City or Town	Conifer
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80433
City Area Code	303
Local Phone Number	640-3838
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	OBLG
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		2,580,370
Entity Central Index Key	0000746210
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Amendment Flag	false

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash	$ 3,714	$ 3,085
Accounts receivable, net	392	415
Inventory, net	634	723
Prepaid expenses and other current assets	947	649
Total current assets	5,687	4,872
Property and equipment, net	3	3
Intangibles, net	518	604
Operating lease - right of use asset, net	99	142
Other assets	31	40
Total assets	6,338	5,661
Current liabilities:
Accounts payable	207	184
Accrued expenses and other current liabilities	1,665	1,074
Current portion of deferred revenue	341	436
Current portion of operating lease liabilities	139	219
Total current liabilities	2,352	1,913
Long-term liabilities:
Operating lease liabilities, net of current portion	0	17
Deferred revenue, net of current portion	84	114
Total liabilities	2,436	2,044
Commitments and contingencies (see Note 11)
Stockholders’ equity:
Preferred stock Series F, convertible; $.0001 par value; $6,550,000 stated value; 42,000 shares authorized, 6,550 and zero shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively	0	0
Common stock, $.0001 par value; 150,000,000 shares authorized; 2,070,861 shares issued and 2,063,308 outstanding at March 31, 2023 and December 31, 2022	0	0
Treasury stock, 7,553 shares of common stock at March 31, 2023 and December 31, 2022	(181)	(181)
Additional paid-in capital	229,149	227,645
Accumulated deficit	(225,066)	(223,847)
Total stockholders' equity	3,902	3,617
Total liabilities and stockholders’ equity	$ 6,338	$ 5,661

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Preferred stock, convertible, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, convertible, stated value	$ 6,550,000	$ 6,550,000
Preferred stock, convertible, shares authorized (in shares)	42,000	42,000
Preferred stock, shares issued (in shares)	6,550	0
Preferred stock, shares outstanding (in shares)	6,550	0
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	150,000,000	150,000,000
Common stock, shares issued (in shares)	2,070,861	2,070,861
Common stock, shares outstanding (in shares)	2,063,308	2,063,308
Treasury stock, shares (in shares)	7,553	7,553

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Revenue	$ 1,038	$ 1,532
Cost of revenue (exclusive of depreciation and amortization)	762	1,033
Gross profit	276	499
Operating expenses:
Research and development	6	1,004
Sales and marketing	218	562
General and administrative	1,169	1,690
Impairment charges	0	1,138
Depreciation and amortization	86	627
Total operating expenses	1,479	5,021
Loss from operations	(1,203)	(4,522)
Interest and other expense, net	5	6
Other income	(27)	0
Interest and other (income) expense, net	(22)	6
Loss before income taxes	(1,181)	(4,528)
Income tax expense	38	11
Net loss	(1,219)	(4,539)
Warrant Modification	25	0
Net loss attributable to common stockholders	$ (1,244)	$ (4,539)
Net loss attributable to common stockholders per share:
Basic net loss per share (in dollars per share)	$ (0.60)	$ (2.20)
Diluted net loss per share (in dollars per share)	$ (0.60)	$ (2.20)
Weighted-average number of shares of common stock:
Basic (in shares)	2,065	2,065
Diluted (in shares)	2,065	2,065

XML

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Preferred Stock Series F Preferred Stock	Common Stock	Treasury Stock	Additional Paid-In Capital	Accumulated Deficit
Common stock, beginning balance (in shares) at Dec. 31, 2021			2,071,000
Treasury stock, beginning balance (in shares) at Dec. 31, 2021				8,000
Beginning balance at Dec. 31, 2021	$ 25,497		$ 0	$ (181)	$ 227,584	$ (201,906)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(4,539)					(4,539)
Stock-based compensation	52				52
Forfeiture of unvested stock options	(84)				(84)
Common stock, ending balance (in shares) at Mar. 31, 2022			2,071,000
Treasury stock, ending balance (in shares) at Mar. 31, 2022				8,000
Ending balance at Mar. 31, 2022	$ 20,926		$ 0	$ (181)	227,552	(206,445)
Preferred stock, beginning balance (in shares) at Dec. 31, 2022	0	0
Common stock, beginning balance (in shares) at Dec. 31, 2022	2,063,308		2,071,000
Treasury stock, beginning balance (in shares) at Dec. 31, 2022	7,553			8,000
Beginning balance at Dec. 31, 2022	$ 3,617	$ 0	$ 0	$ (181)	227,645	(223,847)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(1,219)					(1,219)
Stock-based compensation	31				31
Proceeds from private placement, net of fees and amounts held in escrow (in shares)		6,550
Proceeds from private placement, net of fees and amounts held in escrow	$ 1,473				1,473
Preferred stock, ending balance (in shares) at Mar. 31, 2023	6,550	6,550
Common stock, ending balance (in shares) at Mar. 31, 2023	2,063,308	0	2,071,000
Treasury stock, ending balance (in shares) at Mar. 31, 2023	7,553			8,000
Ending balance at Mar. 31, 2023	$ 3,902		$ 0	$ (181)	$ 229,149	$ (225,066)

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net loss	$ (1,219)	$ (4,539)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	86	627
Bad debt (recovery) expense	(24)	111
Non-cash lease expense from right-of-use asset	43	127
Stock-based compensation	31	52
Forfeiture of unvested stock options	0	(84)
Impairment charges - goodwill	0	1,138
Changes in operating assets and liabilities:
Accounts receivable	47	183
Inventory	89	103
Prepaid expenses and other current assets	(298)	(360)
Other assets	9	45
Accounts payable	23	294
Accrued expenses and other current liabilities	591	188
Deferred revenue	(125)	(126)
Lease liabilities	(97)	(163)
Net cash used in operating activities	(844)	(2,404)
Cash flows from investing activities:
Purchases of property and equipment	0	(11)
Proceeds from sale of equipment	0	1
Net cash used in investing activities	0	(10)
Cash flows from financing activities:
Proceeds from private placement, net of issuance costs and amounts in escrow	1,473	0
Net cash provided by financing activities	1,473	0
Increase (decrease) in cash and restricted cash	629	(2,414)
Cash and restricted cash at beginning of period	3,085	9,000
Cash and restricted cash at end of period	3,714	6,586
Reconciliation of cash and restricted cash
Cash	3,714	6,525
Restricted cash	0	61
Total cash and restricted cash	3,714	6,586
Cash paid during the period for interest	2	0
Cash paid for income taxes	31	0
Non-cash investing and financing activities:
Warrant Modification	$ 25	$ 0

XML

Business Description and Significant Accounting Policies

3 Months Ended

Mar. 31, 2023

Accounting Policies [Abstract]

Business Description and Significant Accounting Policies

Note 1 - Business Description and Significant Accounting Policies

Business Description

Oblong, Inc. (“Oblong” or “we” or “us” or the “Company”) was formed as a Delaware corporation in May 2000 and is a provider of patented multi-stream collaboration technologies and managed services for video collaboration and network applications.

Basis of Presentation

The Company's fiscal year ends on December 31 of each calendar year. The accompanying interim Condensed Consolidated Financial Statements are unaudited and have been prepared on substantially the same basis as our annual Consolidated Financial Statements for the fiscal year ended December 31, 2022. In the opinion of the Company's management, these interim Condensed Consolidated Financial Statements reflect all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.

The December 31, 2022 year-end Condensed Consolidated Balance Sheet data in this document was derived from audited consolidated financial statements. The Condensed Consolidated Financial Statements and notes included in this quarterly report on Form 10-Q do not include all disclosures required by U.S. generally accepted accounting principles and should be read in conjunction with the Company's audited consolidated financial statements as of and for the year ended December 31, 2022 and notes thereto included in the Company's fiscal 2022 Annual Report on Form 10-K, filed with the Securities and Exchange Commission (“SEC”) on March 21, 2023 (the “2022 10-K”).

The results of operations and cash flows for the interim periods included in these Condensed Consolidated Financial Statements are not necessarily indicative of the results to be expected for any future period or the entire fiscal year.

Principles of Consolidation

The Condensed Consolidated Financial Statements include the accounts of Oblong and our 100%-owned subsidiaries (i) GP Communications, LLC (“GP Communications”), whose business function is to provide interstate telecommunications services for regulatory purposes, and (ii) Oblong Industries, Inc. All inter-company balances and transactions have been eliminated in consolidation. The U.S. Dollar is the functional currency for all subsidiaries.

Segments

The Company currently operates in two segments: (1) “Collaboration Products” which represents the business surrounding our Mezzanine™ product offerings, and (2) “Managed Services” which represents the business surrounding managed services for video collaboration and network solutions. See Note 10 - Segment Reporting for further discussion.

Use of Estimates

Preparation of the Condensed Consolidated Financial Statements in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual amounts could differ from the estimates made. We continually evaluate estimates used in the preparation of our consolidated financial statements for reasonableness. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation. The significant areas of estimation include determining the allowance for doubtful accounts, the estimated lives and recoverability

of intangible assets, the inputs used in the valuation of intangible assets in connection with our impairment test, and the inputs used in the fair value of equity-based awards.

Significant Accounting Policies

The significant accounting policies used in preparation of these Condensed Consolidated Financial Statements are disclosed in our 2022 10-K, and there have been no changes to the Company’s significant accounting policies during the three months ended March 31, 2023.

Recently Issued Accounting Pronouncements

In June 2016 the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326),” which was subsequently amended in February 2020 by ASU 2020-02, “Financial Instruments - Credit Losses (Topic 326) and Leases (Topic 842).” The amendments introduce an impairment model that is based on expected credit losses, rather than incurred losses, to estimate credit losses on certain types of financial instruments (e.g., loans and held-to-maturity securities), including certain off-balance sheet financial instruments (e.g., loan commitments). The expected credit losses should consider historical information, current information, and reasonable and supportable forecasts, including estimates of prepayments, over the contractual term. Financial instruments with similar risk characteristics may be grouped together when estimating expected credit losses. The update was effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company adopted the new guidance, as of January 1, 2023, and it did not have a material impact on the Condensed Consolidated Financial Statements.

XML

Liquidity and Going Concern Uncertainty

3 Months Ended

Mar. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Liquidity and Going Concern Uncertainty

Note 2 - Liquidity and Going Concern Uncertainty

As of March 31, 2023, we had $3,714,000 in cash and working capital of $3,335,000. For the three months ended March 31, 2023, we incurred a net loss of $1,219,000 and used $844,000 of net cash in operating activities.

Equity Private Placement

On March 30, 2023, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which we issued and sold, in a private placement transaction (the “Private Placement”), (i) 6,550 shares (the “Preferred Shares”) of our newly designated Series F convertible preferred stock, $0.0001 par value per share (the “Series F Preferred Stock”), initially convertible into up to 3,830,409 shares of our Common Stock, (ii) preferred warrants (“Preferred Warrants”) to acquire 32,750 shares of Series F Preferred Stock, and (iii) common warrants (“Common Warrants” and with the Preferred Warrants the “Investor Warrants”) to acquire up to 3,830,413 shares of Common Stock. The terms of the Series F Preferred Stock are as set forward in the Certificate of Designations of Series F Preferred Stock of Oblong, Inc. (the “Certificate of Designations”), which was filed and became effective with the Secretary of State of the State of Delaware on March 31, 2023. The Private Placement closed on March 31, 2023. Please see the discussion in Note 6 - Capital Stock for further details on the Common Warrants and Note 7 - Preferred Stock for further discussion on the Series F Preferred Stock and Preferred Warrants.

The aggregate gross proceeds of the Private Placement are expected to be $6,386,000. All of the Preferred Shares and Investor Warrants were issued at the Closing, but part of the purchase price equivalent to $4,000,000 was placed into an escrow account with American Stock Transfer & Trust Company (the “Escrow”), to be released upon our obtaining stockholder approval permitting the issuance of more than 19.99% of our outstanding shares of Common Stock at less than the Minimum Price (as defined under the Nasdaq Rules) in accordance with Nasdaq listing standards and as otherwise may be required (the “Stockholder Approval”). The Company expects to use the net proceeds from the Private Placement and the proceeds, if any, from the exercise of the Investor Warrants for general corporate purposes and potential strategic alternatives. We have not, nor has anyone on our behalf, initiated any substantive discussions directly or indirectly with any strategic alternatives partner.

In connection to the Private Placement, pursuant to an engagement letter dated March 30, 2023 (the “Engagement Letter”), between the Company and Dawson James Securities, Inc. (the “Placement Agent”), the Company agreed to (i) pay the Placement Agent a cash fee equal to 8% of the aggregate gross proceeds raised in the Private Placement, and (ii) grant to the Placement Agent warrants (the “Placement Agent Warrants”) to purchase 306,433 shares of Common Stock at an initial exercise price of $1.71 per share. Additionally, we agreed to reimburse the Placement Agent for certain expenses incurred in connection with the Private Placement and to pay certain contingent fees upon the occurrence of specified future events. Please see the discussion in Note 6 - Capital Stock for further details on the Placement Agent Warrants.

Future Capital Requirements and Going Concern

Our capital requirements in the future will continue to depend on numerous factors, including the potential release of the Escrow, the amount of revenue the Company is able to generate, customer renewal rates and the timing of collection of outstanding accounts receivable, in each case particularly as it relates to the Company’s major customers, the expense to deliver services, expense for sales and marketing, and expense for research and development. The Company believes that, in the event the Escrow is not released, based on its current projection of revenue, expenses, and cash flows, it will not have sufficient resources to fund its operations for the next twelve months following the filing of this Report. We believe additional capital will be required to fund operations and provide growth capital including investments in technology, product development and sales and marketing. To access capital to fund operations or provide growth capital, we will need to raise capital in one or more debt and/or equity offerings. There can be no assurance that we will be successful in raising necessary capital or that any such offering will be on terms acceptable to the Company. If we are unable to raise additional capital that may be needed on terms acceptable to us, it could have a material adverse effect on the Company. The factors discussed above raise substantial doubt as to our ability to continue as a going concern. The accompanying Condensed Consolidated Financial Statements do not include any adjustments that might result from these uncertainties.

XML

Intangible Assets and Goodwill

3 Months Ended

Mar. 31, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets and Goodwill

Note 3 - Intangible Assets and Goodwill

Intangioble Assets

The following table presents the components of net intangible assets for our Collaboration Products reporting segment (in thousands):

	As of March 31, 2023						As of December 31, 2022
	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Developed technology	$	486	$	(121)	$	365	$	486	$	(61)	$	425
Trade names	204		(51)		153		204		(25)		179
Total	$	690	$	(172)	$	518	$	690	$	(86)	$	604

At each reporting period, we determine if there was a triggering event that may result in an impairment of our intangible assets. During the three months ended March 31, 2023, we considered the declines in revenue for the Collaboration Products reporting segment to be a triggering event for an impairment test of intangible assets for this segment. Based on the fair value of the asset group, which was determined using a market approach, no impairment charges were recorded for the three months ended March 31, 2023.

Related amortization expense was $86,000 and $580,000 for the three months ended March 31, 2023 and 2022, respectively.

Amortization expense for each of the next five succeeding years will be as follows (in thousands):

Remainder of 2023	$	260
2024	258
Total	$	518

Goodwill

During 2022, Goodwill was written down to zero with an impairment charge of $1,138,000 during the three months ended March 31, 2022, and a subsequent impairment charge of $6,229,000 during the three months ended June 30, 2022.

XML

Accrued Expenses and Other Current Liabilities

3 Months Ended

Mar. 31, 2023

Other Liabilities Disclosure [Abstract]

Accrued Expenses and Other Current Liabilities

Note 4 - Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	March 31,		December 31,
	2023		2022
Compensation costs	$	779	$	707
Customer deposits	271		128
Professional fees	344		57
Taxes and regulatory fees	43		59
Other accrued expenses and liabilities	77		123
Rent expense	151		—
Accrued expenses and other liabilities	$	1,665	$	1,074

XML

Leases

3 Months Ended

Mar. 31, 2023

Leases [Abstract]

Leases

Note 5 - Leases

We lease three facilities in Los Angeles, California providing office space and one facility in City of Industry, California, providing warehouse space. These leases expire between 2023 and 2024. We currently occupy the warehouse space in City of Industry; however, we do not occupy any of the office space in Los Angeles. We have a sublease in place for one of the Los Angeles, California office spaces. With the exception of these spaces described above, we currently operate out of remote employment sites with a remote office located at 25587 Conifer Road, Suite 105-231, Conifer, Colorado 80433.

Lease expenses, net of common charges, for the three months ended March 31, 2023 and 2022, were $46,000 and $139,000, respectively. Sublease proceeds for the three months ended March 31, 2023 and 2022, were $16,000 and $66,000, respectively.

The following provides balance sheet information related to leases as of March 31, 2023 and December 31, 2022 (in thousands):

		March 31, 2023		December 31, 2022
Assets
	Operating lease, right-of-use asset, net	$	99	$	142
Liabilities
	Current portion of operating lease liabilities	$	139	$	219
	Operating lease liabilities, net of current portion	—		17
	Total operating lease liabilities	$	139	$	236

During the three months ended March 31, 2023 and 2022, payments of $100,000 and $173,000 were made on leases, respectively. The following table summarizes the future undiscounted cash payments reconciled to the lease liability (in thousands):

Remaining Lease Payments
2023	$	125
2024	17
Total lease payments	142
Effect of discounting	(3)
Total lease liability	$	139

The following table provides a reconciliation of activity for our right-of-use (“ROU”) assets and lease liabilities (in thousands):

	Right-of-Use Asset		Operating Lease Liabilities
Balance at December 31, 2021	$	659	$	728
Additions	11		11
Non-cash lease expense and payments	(349)		(503)
Impairment charges	(179)		—
Balance at December 31, 2022	142		236
Additions	—		—
Terminations and modifications	$	—	$	—
Non-cash lease expense and payments	(43)		(97)
Impairment charges	—		—
Balance at March 31, 2023	$	99	$	139

The ROU assets and lease liabilities are recorded on the Company’s Condensed Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022.

XML

Capital Stock

3 Months Ended

Mar. 31, 2023

Equity [Abstract]

Capital Stock

Note 6 - Capital Stock

Common Stock

On January 3, 2023, the Company effected a 1-for-15 reverse stock split of its Common Stock. All Common Stock share information (including treasury share information) in our Condensed Consolidated Financial Statements and has been adjusted for this stock split retrospectively for all periods represented herein.

The Company’s common stock, par value $0.0001 per share (the “Common Stock”), is listed on the Nasdaq Capital Market (“Nasdaq”), under the ticker symbol “OBLG”. As of March 31, 2023, we had 150,000,000 shares of our Common Stock authorized, with 2,070,861 and 2,063,308 shares issued and outstanding, respectively.

The Company did not issue any shares of Common Stock during the three months ended March 31, 2023.

On April 18, 2023, the Company issued 339,498 shares of Common Stock in relation to certain warrant exercises discussed below, and 177,564 shares of Common Stock related to vested RSUs discussed in Note 8 - Stock Based Compensation.

Common Stock Warrants

As described in Note 2, in connection with the Private Placement, on March 31, 2023, the Company issued the Common Warrants and Placement Agent Warrants to purchase an aggregate of 4,136,846 shares of the Company’s Common Stock. The Common Warrants and Placement Agent Warrants have a term of 5 years, commencing six months and one day from the date of issuance, and are initially exercisable for $1.71 per share. The exercise price is subject to customary adjustments for stock splits, stock dividends, stock combination, recapitalization, or other similar transactions involving the Common Stock, and subject to price-based adjustment, on a full ratchet basis, in the event of any issuances of Common Stock, or securities convertible, exercisable or exchangeable for Common Stock, at a price below the then-applicable exercise price for the Common Warrants (subject to certain exceptions). The Common Warrants and Placement Agent Warrants are exercisable for cash, provided that if there is no effective registration statement available permitting the resale of the common shares, they may be exercised on a cashless basis. Exercise of the Common Warrants and Placement Agent Warrants is subject to certain limitations, including a 4.99% beneficial ownership limitation. The fair value of the warrants was recorded within additional paid-in capital during the three months ended March 31, 2023.

Warrants outstanding as of March 31, 2023 are as follows:

Issue Date	Warrants Issued	Exercise Price		Expiration Date
October 21, 2020	34,767	$	61.20	April 22, 2023
December 6, 2020	41,667	82.35		June 7, 2023
June 28, 2021	66,667	60.00		January 4, 2024 (a)
June 28, 2021	200,000	66.00		June 28, 2024
March 31, 2023	4,136,846	$	1.71	September 30, 2028
	4,479,947

(a) On January 3, 2023, the Company and all the holders of the Series A Warrants agreed to amend the terms of the Series A Warrants to extend the termination date from January 4, 2023 to January 4, 2024. All other terms of the Series A Warrants will remain in full force and effect. The modification resulted in an incremental value adjustment, and deemed dividend, of $25,000, which was recorded within additional paid-in capital during the three months ended March 31, 2023.

On April 18, 2023, the Company entered into warrant exercise inducement offer letters with certain holders of outstanding warrants to purchase shares of the Company’s common stock originally issued on October 21, 2020, December 6, 2020, and June 28, 2021, as reflected in the table above (such holders the “Exercising Holders” and such warrants the “Existing Warrants”) pursuant to which the Exercising Holders agreed to exercise, for cash, Existing Warrants to purchase, in the aggregate, 339,498 shares of the Company’s common stock (the “Existing Warrant Shares”), in exchange for the Company’s agreement to lower the exercise price of the Existing Warrants to $1.71. The Company received net proceeds of $534,000 from the exercise of the Existing Warrants in April 2023 (net of $46,000 of financing costs). Following the exercise of the Existing Warrants, an aggregate of 3,603 Existing Warrants remained outstanding.

Warrant activity for the three months ended March 31, 2023 and the year ended December 31, 2022 is presented below.

	Outstanding
	Number of Warrants	Weighted Average Exercise Price
Warrants outstanding and exercisable, December 31, 2021	343,101	$	66.34
Warrants outstanding and exercisable, December 31, 2022	343,101	66.34
Granted	4,136,846	1.71
Warrants outstanding and exercisable, March 31, 2023	4,479,947	$	6.66

Treasury Shares

The Company maintains treasury stock for the Common Stock shares bought back by the Company when withholding shares to cover taxes on transactions related to equity awards. There were no treasury stock transactions during the three months ended March 31, 2023 or the year ended December 31, 2022.

XML

Preferred Stock

3 Months Ended

Mar. 31, 2023

Equity [Abstract]

Preferred Stock

Note 7 - Preferred Stock

Our Certificate of Incorporation authorizes the issuance of up to 5,000,000 shares of preferred stock. As of March 31, 2023, we had 1,983,250 designated shares of preferred stock and 6,550 shares of preferred stock issued and outstanding. As of December 31, 2022, we had no shares of preferred stock outstanding.

Series F Preferred Stock

As described in Note 2, on March 31, 2023, the Company closed a Private Placement and issued (i) 6,550 shares of our newly designated Series F Preferred Stock and (ii) Preferred Warrants to acquire 32,750 shares of Series F Preferred Stock.

As of March 31, 2023, the Company recorded net proceeds from the Private Placement of $1,473,000 to stockholders’ equity. The net proceeds included $6,386,000 in gross proceeds, less (i) $4,000,000 that is being held in escrow and (ii) $913,000 in financing costs.

The Series F Preferred Shares are convertible into fully paid and non-assessable shares of the Company’s Common Stock at the election of the holder at any time at an initial conversion price of $1.71 (the “Conversion Price”). The holders of the Series F Preferred Shares may also elect to convert their shares at an alternative conversion price equal to the lower of (i) 80% of the applicable Conversion Price as in effect on the date of the conversion, (ii) 80% of the closing price on the trading day immediately preceding the delivery of the conversion notice, and (iii) the greater of (a) the Floor Price (as defined in the Certificate of Designations) and (b) the quotient of (x) the sum of the five lowest Closing Bid Prices (as defined in the Certificate of Designations) for trading days in the 30 consecutive trading day period ending and including the trading day immediately preceding the delivery of the applicable Conversion Notice, divided by (y) five, provided that that such price may not be lower than the Minimum Price (as defined under the Nasdaq Rules) prior to obtaining Stockholder Approval for the issuance. The Conversion Price is subject to customary adjustments for stock splits, stock dividends, stock combination recapitalization, or other similar transactions involving the Common Stock, and subject to price-based adjustment, on a full ratchet basis, in the event of any issuances of our common stock, or securities convertible, exercisable or exchangeable for Common Stock, at a price below the then-applicable Conversion Price (subject to certain exceptions).

Under the Certificate of Designations, the Series F Preferred Shares have an initial stated value of $1,000 per share (the “Stated Value”). The holders of the Series F Preferred Shares are entitled to dividends of 9% per annum, which will be payable in arrears quarterly. Accrued dividends may be paid, at our option, in cash and if not paid, shall increase the stated value of the Series F Preferred Shares. Upon the occurrence and during the continuance of a Triggering Event (as defined in the Certificate of Designations), the Series F Preferred Shares will accrue dividends at the rate of 20% per annum (the “Default Rate”). The Series F Preferred Shares have no voting rights, other than with respect to certain matters affecting the rights of the Series F Preferred Shares. On matters with respect to which the holders of the Series F Preferred Shares have a right to vote, holders of the Preferred Shares will have voting rights on an as-converted basis, provided that until receipt of Stockholder Approval, any adjustment to the Conversion Price shall not cause the Conversion Price for voting purposes to be less than the Minimum Price (as defined in Nasdaq Listing Rule 5635(d)).

Our ability to settle conversions is subject to certain limitations set forth in the Certificate of Designations, including a limit on the number of shares of Common Stock that may be issued until the time that the Stockholder Approval is obtained permitting the issuance of more than 19.99% of our outstanding shares of Common Stock in accordance with Nasdaq listing standards. We agreed to seek Stockholder Approval of these matters at a meeting to be held no later than May 31, 2023. Further, the Certificate of Designations contains a certain beneficial ownership limitation after giving effect to the issuance of shares of common stock issuable upon conversion of the Series F Preferred Shares.

The Certificate of Designations includes certain Triggering Events (as defined in the Certificate of Designations), including, among other things, (i) the failure to file and maintain an effective registration statement covering the sale of the holder’s securities registrable pursuant to the Registration Rights Agreement, (ii) the failure to pay any amounts due to the holders of the Series F Preferred Shares when due, and (iii) if Peter Holst ceases to be the chief executive officer of the Company other than because of his death, and a qualified replacement, reasonably acceptable to a majority of the holders of the Series F Preferred Shares, is not appointed within thirty (30) business days. In connection with a Triggering Event, the Default Rate is triggered. The Default Rate is also triggered in the event that we are unable, from the failure to obtain the Stockholder Approval prior to May 31, 2023 (the “Approval Date”), to issue shares of Common Stock in connection with a conversion of the Series F Preferred Stock after the Approval Date. We are subject to certain affirmative and negative covenants regarding the incurrence of indebtedness, acquisition transactions, the existence of liens, the repayment of indebtedness, the payment of cash in respect of dividends (other than dividends pursuant to the Certificate of Designations), maintenance of properties and the transfer of assets, among other matters.

Series F Preferred Stock Warrants

The Preferred Warrants are exercisable for Series F Preferred Shares at an exercise price of $975. The exercise price is subject to customary adjustments for stock splits, stock dividends, stock combination recapitalizations or other similar transactions involving the Common Stock. The Preferred Warrants expire three years from the date of issuance and are exercisable for cash. For each Preferred Warrant exercised, the Investors shall receive Common Warrants to purchase a number of shares of Common Stock equal to 100% of the number of shares of Common Stock the Investors would receive if the Series F Preferred Shares issuable upon exercise of such Warrant were converted at the applicable Conversion Price. The fair value of the Preferred Warrants was recorded within additional paid-in capital during the three months ended March 31, 2023.

XML

Stock Based Compensation

3 Months Ended

Mar. 31, 2023

Share-Based Payment Arrangement [Abstract]

Stock Based Compensation

Note 8 - Stock Based Compensation

On January 3, 2023, the Company effected a 1-for-15 reverse stock split for its Common Stock. All Common Stock share information in the following net loss per share discussion and tables are shown as adjusted for this stock split retrospectively for all periods represented herein.

2019 Equity Incentive Plan

On December 19, 2019, the Oblong, Inc. 2019 Equity Incentive Plan (the “2019 Plan”) was approved by the Company’s stockholders at the Company’s 2019 Annual Meeting of Stockholders. The 2019 Plan is an omnibus equity incentive plan pursuant to which the Company may grant equity and cash incentive awards to certain key service providers of the Company and its subsidiaries. As of March 31, 2023, the share pool available for new grants under the 2019 Plan is 177,567. On April 18, 2023, 177,564 restricted stock units were granted to certain members of the board, reducing the share pool available for new grants under the 2019 Plan to 3.

Stock Options

During the three months ended March 31, 2023 and 2022, no stock options were granted and 6,501 and 334 vested stock options expired, respectively. During the three months ended March 31, 2022, 10,000 unvested stock options were forfeited.

A summary of stock options granted, expired, and forfeited under our plans, and options outstanding as of, and changes made during the three months ended March 31, 2023 and year ended December 31, 2022 is presented below:

	Outstanding			Exercisable
	Number of Options	Weighted Average Exercise Price		Number of Options	Weighted Average Exercise Price
Options outstanding and exercisable, December 31, 2021	27,169	$	113.63	7,169	$	—
Vested	—	—		3,332	48.75
Expired	(501)	410.18		(501)	410.18
Forfeited	(10,000)	48.75		—	—
Options outstanding and exercisable, December 31, 2022	16,668	143.63		10,000	206.85
Expired	(6,501)	289.77		(6,501)	289.77
Options outstanding and exercisable, March 31, 2023	10,167	$	50.17	3,499	$	52.87

Additional information as of March 31, 2023 is as follows:

	Outstanding				Exercisable
Range of price	Number of Options	Weighted Average Remaining Contractual Life (In Years)	Weighted Average Exercise Price		Number of Options	Weighted Average Exercise Price
$0.00 – $100.00	10,000	8.25	$	48.75	3,332	$	48.75
$100.01 – $200.00	167	0.25	135.00		167	135.00
	10,167	8.12	$	50.17	3,499	$	52.87

The intrinsic value of vested and unvested options was not significant for all periods presented. Stock compensation expense, related to stock options, for the three months ended March 31, 2023 was $31,000. Net stock compensation expense, related to stock options, was a negative $32,000, made up of $52,000 in expense offset by $84,000 related to forfeiture credits, for the three months ended March 31, 2022. The remaining unrecognized stock-based compensation expense for options as of March 31, 2023 is $154,000, which will be recognized over a weighted average period of 1.25 years.

Restricted Stock Awards

As of March 31, 2023, there were 42 unvested restricted stock awards outstanding, with a weighted average grant date price of $235.87. The awards were issued in 2014 and vest over the lesser of ten years, a change in control, or separation from the company. Due to the variability of the vesting, the expense was amortized over an average service period of five years, therefore, there is no unrecognized stock-based compensation expense for restricted stock awards as of March 31, 2023.

Restricted Stock Units

As of March 31, 2023, there were no unvested restricted stock units (“RSUs”) outstanding. As of March 31, 2023, 1,929 vested RSUs remain outstanding as shares of common stock have not yet been delivered for these units in accordance with the terms of the RSUs.

There was no stock compensation expense related to RSUs for the three months ended March 31, 2023 and 2022. There was no remaining unrecognized stock-based compensation expense for RSUs as of March 31, 2023.

On April 18, 2023, 177,564 RSUs were granted to certain board members. These RSUs vested immediately upon issuance.

XML

Net Loss Per Share

3 Months Ended

Mar. 31, 2023

Earnings Per Share [Abstract]

Net Loss Per Share

Note 9 - Net Loss Per Share

On January 3, 2023, the Company effected a 1-for-15 reverse stock split for its Common Stock. All Common Stock share information in the following net loss per share discussion and tables are shown as adjusted for this stock split retrospectively for all periods represented herein.

Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. The weighted-average number of shares of common stock outstanding does not include any potentially dilutive securities or unvested restricted stock. Unvested restricted stock, although classified as issued and outstanding at March 31, 2023 and 2022, is considered contingently returnable until the restrictions lapse and will not be included in the basic net loss per share calculation until the shares are vested. Unvested restricted stock does not contain non-forfeitable rights to dividends and dividend equivalents. Unvested RSUs are not included in calculations of basic net loss per share, as they are not considered issued and outstanding at time of grant.

Diluted net loss per share is computed by giving effect to all potential shares of common stock, including stock options, preferred stock, RSUs, and unvested restricted stock, to the extent they are dilutive. For the three months ended March 31, 2023 and 2022, all such common stock equivalents have been excluded from diluted net loss per share as the effect to net loss per share would be anti-dilutive (due to the net loss).

The following table sets forth the computation of the Company’s basic and diluted net loss per share (in thousands, except per share data):

	Three Months Ended March 31,
	2023		2022
Numerator:
Net loss	$	(1,219)	$	(4,539)
Less: warrant modification	$	(25)	$	—
Net loss attributable to common stockholders	$	(1,244)	$	(4,539)
Denominator:
Weighted-average number of shares of common stock for basic and diluted net loss per share	2,065		2,065
Basic and diluted net loss per share	$	(0.60)	$	(2.20)

The following table represents the potential shares that were excluded from the computation of weighted-average number of shares of common stock in computing the diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect (due to the net loss):

	Three Months Ended March 31,
	2023	2022
Unvested restricted stock awards	42	42
Outstanding stock options	10,167	16,835
Common stock issuable upon conversion of Series F Preferred Stock	3,830,409	—
Warrants	4,479,947	343,101

XML

Segment Reporting

3 Months Ended

Mar. 31, 2023

Segment Reporting [Abstract]

Segment Reporting

Note 10 - Segment Reporting

The Company currently operates in two segments: (1) “Managed Services”, which represents the business surrounding managed services for video collaboration and network applications; and (2) “Collaboration Products” which represents the business surrounding our Mezzanine™ product offerings.

Certain information concerning the Company’s segments for the three months ended March 31, 2023 and 2022 is presented in the following tables (in thousands):

	Three Months Ended March 31, 2023
	Managed Services			Collaboration Products			Corporate		Total
Revenue	$	690		$	348		$	—	$	1,038
Cost of revenues	460			302			—		762
Gross profit	$	230		$	46		$	—	$	276
Gross profit %	33		%	13		%			27		%
Allocated operating expenses	$	—		$	286		$	—	$	286
Unallocated operating expenses	—			—			1,193		1,193
Total operating expenses	$	—		$	286		$	1,193	$	1,479
Income (loss) from operations	$	230		$	(240)		$	(1,193)	$	(1,203)
Interest and other expense (income), net	3			(25)			—		(22)
Net income (loss) before tax	233			(215)			(1,193)		(1,181)
Income tax expense	7			31			—		38
Net income (loss)	$	226		$	(246)		$	(1,193)	$	(1,219)

	Three Months Ended March 31, 2022
	Managed Services			Collaboration Products			Corporate		Total
Revenue	$	966		$	566		$	—	$	1,532
Cost of revenues	645			388			—		1,033
Gross profit	$	321		$	178		$	—	$	499
Gross profit %	33		%	31		%			33		%
Allocated operating expenses	$	56		$	3,425		$	—	$	3,481
Unallocated operating expenses	—			—			1,540		1,540
Total operating expenses	$	56		$	3,425		$	1,540	$	5,021
Income (loss) from operations	$	265		$	(3,247)		$	(1,540)	$	(4,522)
Interest and other expense (income), net	6			—			—		6
Income (loss) before income taxes	271			(3,247)			(1,540)		(4,528)
Income tax expense	9			2			—		11
Net income (loss)	$	262		$	(3,249)		$	(1,540)	$	(4,539)

Unallocated operating expenses in Corporate include costs for the three months ended March 31, 2023 and 2022 that are not specific to a particular segment but are general to the group; included are expenses incurred for administrative and accounting staff, general liability and other insurance, professional fees and other similar corporate expenses.

For the three months ended March 31, 2023, there was no material revenue attributable to any individual foreign country. For three months ended March 31, 2022, approximately 12% of revenue was attributable to the United Kingdom.

Revenue by geographic area is allocated as follows (in thousands):

	Three Months Ended March 31,
	2023		2022
Domestic	$	563	$	843
Foreign	475		689
	$	1,038	$	1,532

Disaggregated information for the Company’s revenue has been recognized in the accompanying Condensed Consolidated Statements of Operations and is presented below according to contract type (in thousands):

	Three Months Ended March 31,
	2023		% of Revenue		2022		% of Revenue
Revenue: Managed Services
Video collaboration services	$	64	6	%	$	116	7	%
Network services	618		60	%	821		54	%
Professional and other services	8		1	%	29		2	%
Total Managed Services revenue	$	690	67	%	$	966	63	%
Revenue: Collaboration Products
Visual collaboration product offerings	$	348	33	%	$	562	37	%
Licensing	—		—	%	4		—	%
Total Collaboration Products revenue	348		33	%	566		37	%
Total revenue	$	1,038	100	%	$	1,532	100	%

The Company considers a significant customer to be one that comprises more than 10% of the Company’s consolidated revenues or accounts receivable. The loss of or a reduction in sales or anticipated sales to our most significant or several of our smaller customers could have a material adverse effect on our business, financial condition and results of operations.

Concentration of revenues was as follows:

		Three Months Ended March 31,
		2023		2022
	Segment	% of Revenue		% of Revenue
Customer A	Managed Services	52	%	44	%

Concentration of accounts receivable was as follows:

		As of March 31, 2023
		2023		2022
	Segment	% of Accounts Receivable		% of Accounts Receivable
Customer A	Managed Services	41	%	38	%
Customer B	Managed Services	11	%	—	%
Customer C	Collaboration Products	14	%	—	%
Customer D	Collaboration Products	15	%	—	%
Customer E	Collaboration Products	—	%	13	%
Customer F	Collaboration Products	—	%	10	%

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 11 - Commitments and Contingencies

From time to time, we are subject to various legal proceedings arising in the ordinary course of business, including proceedings for which we have insurance coverage. As of the date hereof, we are not party to any legal proceedings that we currently believe will have a material adverse effect on our business, financial position, results of operations or liquidity.

COVID-19

On March 11, 2020, the World Health Organization (“WHO”) announced that infections of the novel Coronavirus (COVID-19) had become pandemic, and on March 13, 2020, the U.S. President announced a National Emergency relating to the disease. In May 2023, the WHO declared COVID-19 over as a global health emergency. Customers generally use our Mezzanine™ products in traditional office and operating center environments such as conference rooms or other presentation

spaces. Revenue declines for our Collaboration Products business are primarily attributable to the aftermath of the COVID-19 pandemic on our existing and target customers as they continue to evaluate behavioral changes in how and when employees choose to work from traditional office environments, resulting in delayed buying decisions for our Collaboration Products. Continuation of the ongoing effects of the COVID-19 pandemic, could cause further disruptions to our operations and the operations of our customers, suppliers and logistics partners and could significantly adversely affect our near-term and long-term revenues, earnings, liquidity and cash flows.

XML

Business Description and Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2023

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The Company's fiscal year ends on December 31 of each calendar year. The accompanying interim Condensed Consolidated Financial Statements are unaudited and have been prepared on substantially the same basis as our annual Consolidated Financial Statements for the fiscal year ended December 31, 2022. In the opinion of the Company's management, these interim Condensed Consolidated Financial Statements reflect all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.

The December 31, 2022 year-end Condensed Consolidated Balance Sheet data in this document was derived from audited consolidated financial statements. The Condensed Consolidated Financial Statements and notes included in this quarterly report on Form 10-Q do not include all disclosures required by U.S. generally accepted accounting principles and should be read in conjunction with the Company's audited consolidated financial statements as of and for the year ended December 31, 2022 and notes thereto included in the Company's fiscal 2022 Annual Report on Form 10-K, filed with the Securities and Exchange Commission (“SEC”) on March 21, 2023 (the “2022 10-K”).

The results of operations and cash flows for the interim periods included in these Condensed Consolidated Financial Statements are not necessarily indicative of the results to be expected for any future period or the entire fiscal year.

Principles of Consolidation

Principles of Consolidation

The Condensed Consolidated Financial Statements include the accounts of Oblong and our 100%-owned subsidiaries (i) GP Communications, LLC (“GP Communications”), whose business function is to provide interstate telecommunications services for regulatory purposes, and (ii) Oblong Industries, Inc. All inter-company balances and transactions have been eliminated in consolidation. The U.S. Dollar is the functional currency for all subsidiaries.

Segments

Segments

The Company currently operates in two segments: (1) “Collaboration Products” which represents the business surrounding our Mezzanine™ product offerings, and (2) “Managed Services” which represents the business surrounding managed services for video collaboration and network solutions. See Note 10 - Segment Reporting for further discussion.

Use of Estimates

Use of Estimates

Preparation of the Condensed Consolidated Financial Statements in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual amounts could differ from the estimates made. We continually evaluate estimates used in the preparation of our consolidated financial statements for reasonableness. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation. The significant areas of estimation include determining the allowance for doubtful accounts, the estimated lives and recoverability

of intangible assets, the inputs used in the valuation of intangible assets in connection with our impairment test, and the inputs used in the fair value of equity-based awards.

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

In June 2016 the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326),” which was subsequently amended in February 2020 by ASU 2020-02, “Financial Instruments - Credit Losses (Topic 326) and Leases (Topic 842).” The amendments introduce an impairment model that is based on expected credit losses, rather than incurred losses, to estimate credit losses on certain types of financial instruments (e.g., loans and held-to-maturity securities), including certain off-balance sheet financial instruments (e.g., loan commitments). The expected credit losses should consider historical information, current information, and reasonable and supportable forecasts, including estimates of prepayments, over the contractual term. Financial instruments with similar risk characteristics may be grouped together when estimating expected credit losses. The update was effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company adopted the new guidance, as of January 1, 2023, and it did not have a material impact on the Condensed Consolidated Financial Statements.

XML

Intangible Assets and Goodwill (Tables)

3 Months Ended

Mar. 31, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets

The following table presents the components of net intangible assets for our Collaboration Products reporting segment (in thousands):

	As of March 31, 2023						As of December 31, 2022
	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Developed technology	$	486	$	(121)	$	365	$	486	$	(61)	$	425
Trade names	204		(51)		153		204		(25)		179
Total	$	690	$	(172)	$	518	$	690	$	(86)	$	604

Schedule of Future Amortization Expense

Amortization expense for each of the next five succeeding years will be as follows (in thousands):

Remainder of 2023	$	260
2024	258
Total	$	518

XML

Accrued Expenses and Other Current Liabilities (Tables)

3 Months Ended

Mar. 31, 2023

Other Liabilities Disclosure [Abstract]

Schedule of Accrued Expenses and Other Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	March 31,		December 31,
	2023		2022
Compensation costs	$	779	$	707
Customer deposits	271		128
Professional fees	344		57
Taxes and regulatory fees	43		59
Other accrued expenses and liabilities	77		123
Rent expense	151		—
Accrued expenses and other liabilities	$	1,665	$	1,074

XML

Leases (Tables)

3 Months Ended

Mar. 31, 2023

Leases [Abstract]

Schedule of Balance Sheet Information

The following provides balance sheet information related to leases as of March 31, 2023 and December 31, 2022 (in thousands):

		March 31, 2023		December 31, 2022
Assets
	Operating lease, right-of-use asset, net	$	99	$	142
Liabilities
	Current portion of operating lease liabilities	$	139	$	219
	Operating lease liabilities, net of current portion	—		17
	Total operating lease liabilities	$	139	$	236

Schedule of Future Minimum Rental Payments for Operating Leases

The following table summarizes the future undiscounted cash payments reconciled to the lease liability (in thousands):

Remaining Lease Payments
2023	$	125
2024	17
Total lease payments	142
Effect of discounting	(3)
Total lease liability	$	139

Schedule Of Operating Lease Liability and Right Of Use Assets

The following table provides a reconciliation of activity for our right-of-use (“ROU”) assets and lease liabilities (in thousands):

	Right-of-Use Asset		Operating Lease Liabilities
Balance at December 31, 2021	$	659	$	728
Additions	11		11
Non-cash lease expense and payments	(349)		(503)
Impairment charges	(179)		—
Balance at December 31, 2022	142		236
Additions	—		—
Terminations and modifications	$	—	$	—
Non-cash lease expense and payments	(43)		(97)
Impairment charges	—		—
Balance at March 31, 2023	$	99	$	139

XML

Capital Stock (Tables)

3 Months Ended

Mar. 31, 2023

Equity [Abstract]

Schedule of Warrants Activity

Warrants outstanding as of March 31, 2023 are as follows:

Issue Date	Warrants Issued	Exercise Price		Expiration Date
October 21, 2020	34,767	$	61.20	April 22, 2023
December 6, 2020	41,667	82.35		June 7, 2023
June 28, 2021	66,667	60.00		January 4, 2024 (a)
June 28, 2021	200,000	66.00		June 28, 2024
March 31, 2023	4,136,846	$	1.71	September 30, 2028
	4,479,947

(a) On January 3, 2023, the Company and all the holders of the Series A Warrants agreed to amend the terms of the Series A Warrants to extend the termination date from January 4, 2023 to January 4, 2024. All other terms of the Series A Warrants will remain in full force and effect. The modification resulted in an incremental value adjustment, and deemed dividend, of $25,000, which was recorded within additional paid-in capital during the three months ended March 31, 2023.

Warrant activity for the three months ended March 31, 2023 and the year ended December 31, 2022 is presented below.

	Outstanding
	Number of Warrants	Weighted Average Exercise Price
Warrants outstanding and exercisable, December 31, 2021	343,101	$	66.34
Warrants outstanding and exercisable, December 31, 2022	343,101	66.34
Granted	4,136,846	1.71
Warrants outstanding and exercisable, March 31, 2023	4,479,947	$	6.66

XML

Stock Based Compensation (Tables)

3 Months Ended

Mar. 31, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Options Granted, Exercised, Expired and Forfeited

A summary of stock options granted, expired, and forfeited under our plans, and options outstanding as of, and changes made during the three months ended March 31, 2023 and year ended December 31, 2022 is presented below:

	Outstanding			Exercisable
	Number of Options	Weighted Average Exercise Price		Number of Options	Weighted Average Exercise Price
Options outstanding and exercisable, December 31, 2021	27,169	$	113.63	7,169	$	—
Vested	—	—		3,332	48.75
Expired	(501)	410.18		(501)	410.18
Forfeited	(10,000)	48.75		—	—
Options outstanding and exercisable, December 31, 2022	16,668	143.63		10,000	206.85
Expired	(6,501)	289.77		(6,501)	289.77
Options outstanding and exercisable, March 31, 2023	10,167	$	50.17	3,499	$	52.87

Schedule of Shares Outstanding and Exercisable, By Exercise Price Range

Additional information as of March 31, 2023 is as follows:

	Outstanding				Exercisable
Range of price	Number of Options	Weighted Average Remaining Contractual Life (In Years)	Weighted Average Exercise Price		Number of Options	Weighted Average Exercise Price
$0.00 – $100.00	10,000	8.25	$	48.75	3,332	$	48.75
$100.01 – $200.00	167	0.25	135.00		167	135.00
	10,167	8.12	$	50.17	3,499	$	52.87

XML

Net Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2023

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth the computation of the Company’s basic and diluted net loss per share (in thousands, except per share data):

	Three Months Ended March 31,
	2023		2022
Numerator:
Net loss	$	(1,219)	$	(4,539)
Less: warrant modification	$	(25)	$	—
Net loss attributable to common stockholders	$	(1,244)	$	(4,539)
Denominator:
Weighted-average number of shares of common stock for basic and diluted net loss per share	2,065		2,065
Basic and diluted net loss per share	$	(0.60)	$	(2.20)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following table represents the potential shares that were excluded from the computation of weighted-average number of shares of common stock in computing the diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect (due to the net loss):

	Three Months Ended March 31,
	2023	2022
Unvested restricted stock awards	42	42
Outstanding stock options	10,167	16,835
Common stock issuable upon conversion of Series F Preferred Stock	3,830,409	—
Warrants	4,479,947	343,101

XML

Segment Reporting (Tables)

3 Months Ended

Mar. 31, 2023

Segment Reporting [Abstract]

Schedule of Segment Reporting Information

Certain information concerning the Company’s segments for the three months ended March 31, 2023 and 2022 is presented in the following tables (in thousands):

	Three Months Ended March 31, 2023
	Managed Services			Collaboration Products			Corporate		Total
Revenue	$	690		$	348		$	—	$	1,038
Cost of revenues	460			302			—		762
Gross profit	$	230		$	46		$	—	$	276
Gross profit %	33		%	13		%			27		%
Allocated operating expenses	$	—		$	286		$	—	$	286
Unallocated operating expenses	—			—			1,193		1,193
Total operating expenses	$	—		$	286		$	1,193	$	1,479
Income (loss) from operations	$	230		$	(240)		$	(1,193)	$	(1,203)
Interest and other expense (income), net	3			(25)			—		(22)
Net income (loss) before tax	233			(215)			(1,193)		(1,181)
Income tax expense	7			31			—		38
Net income (loss)	$	226		$	(246)		$	(1,193)	$	(1,219)

	Three Months Ended March 31, 2022
	Managed Services			Collaboration Products			Corporate		Total
Revenue	$	966		$	566		$	—	$	1,532
Cost of revenues	645			388			—		1,033
Gross profit	$	321		$	178		$	—	$	499
Gross profit %	33		%	31		%			33		%
Allocated operating expenses	$	56		$	3,425		$	—	$	3,481
Unallocated operating expenses	—			—			1,540		1,540
Total operating expenses	$	56		$	3,425		$	1,540	$	5,021
Income (loss) from operations	$	265		$	(3,247)		$	(1,540)	$	(4,522)
Interest and other expense (income), net	6			—			—		6
Income (loss) before income taxes	271			(3,247)			(1,540)		(4,528)
Income tax expense	9			2			—		11
Net income (loss)	$	262		$	(3,249)		$	(1,540)	$	(4,539)

Concentration of revenues was as follows:

		Three Months Ended March 31,
		2023		2022
	Segment	% of Revenue		% of Revenue
Customer A	Managed Services	52	%	44	%

Concentration of accounts receivable was as follows:

		As of March 31, 2023
		2023		2022
	Segment	% of Accounts Receivable		% of Accounts Receivable
Customer A	Managed Services	41	%	38	%
Customer B	Managed Services	11	%	—	%
Customer C	Collaboration Products	14	%	—	%
Customer D	Collaboration Products	15	%	—	%
Customer E	Collaboration Products	—	%	13	%
Customer F	Collaboration Products	—	%	10	%

Schedule of Revenue from External Customers by Geographic Areas

Revenue by geographic area is allocated as follows (in thousands):

	Three Months Ended March 31,
	2023		2022
Domestic	$	563	$	843
Foreign	475		689
	$	1,038	$	1,532

Schedule of Disaggregated Revenue Information

Disaggregated information for the Company’s revenue has been recognized in the accompanying Condensed Consolidated Statements of Operations and is presented below according to contract type (in thousands):

	Three Months Ended March 31,
	2023		% of Revenue		2022		% of Revenue
Revenue: Managed Services
Video collaboration services	$	64	6	%	$	116	7	%
Network services	618		60	%	821		54	%
Professional and other services	8		1	%	29		2	%
Total Managed Services revenue	$	690	67	%	$	966	63	%
Revenue: Collaboration Products
Visual collaboration product offerings	$	348	33	%	$	562	37	%
Licensing	—		—	%	4		—	%
Total Collaboration Products revenue	348		33	%	566		37	%
Total revenue	$	1,038	100	%	$	1,532	100	%

XML

Business Description and Significant Accounting Policies (Details)	3 Months Ended
	Mar. 31, 2023 segment
Accounting Policies [Abstract]
Number of operating segments	2

XML

Liquidity and Going Concern Uncertainty (Details) - USD ($) $ / shares in Units, $ in Thousands			3 Months Ended
	Mar. 31, 2023	Mar. 30, 2023	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 06, 2020	Oct. 21, 2020
Class of Stock [Line Items]
Cash	$ 3,714		$ 3,714	$ 6,586	$ 3,085	$ 9,000
Working capital	$ 3,335		3,335
Net loss			(1,219)	(4,539)
Net cash used in operating activities			$ (844)	$ (2,404)
Preferred stock, convertible, par value (in dollars per share)	$ 0.0001		$ 0.0001		$ 0.0001
Exercise price (in dollars per share)	$ 6.66		$ 6.66		$ 66.34	$ 66.34	$ 82.35	$ 61.20
Series F Preferred Stock
Class of Stock [Line Items]
Percentage of common stock to be issued at minimum price	19.99%		19.99%
Exercise price (in dollars per share)	$ 975		$ 975
Private Placement | Preferred Warrants
Class of Stock [Line Items]
Number of shares issuable (in shares)	32,750	32,750	32,750
Private Placement | Investor Warrants
Class of Stock [Line Items]
Number of shares issuable (in shares)		3,830,413
Private Placement | Placement Agent Warrants
Class of Stock [Line Items]
Number of shares issuable (in shares)		306,433
Exercise price (in dollars per share)		$ 1.71
Private Placement | Series F Preferred Stock
Class of Stock [Line Items]
Number of shares issued (in shares)	6,550	6,550
Preferred stock, convertible, par value (in dollars per share)		$ 0.0001
Shares issuable upon conversion (in shares)		3,830,409
Gross proceeds		$ 6,386
Escrow deposit		$ 4,000
Percentage of common stock to be issued at minimum price		19.99%
Percentage of cash fees		8.00%

XML

Intangible Assets and Goodwill - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Business Acquisition [Line Items]
Gross Carrying Amount	$ 690	$ 690
Accumulated Amortization	(172)	(86)
Net Carrying Amount	518	604
Developed technology
Business Acquisition [Line Items]
Gross Carrying Amount	486	486
Accumulated Amortization	(121)	(61)
Net Carrying Amount	365	425
Trade names
Business Acquisition [Line Items]
Gross Carrying Amount	204	204
Accumulated Amortization	(51)	(25)
Net Carrying Amount	$ 153	$ 179

XML

Intangible Assets and Goodwill - Narrative (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Impairment charges - intangible assets	$ 0
Amortization expense	86,000		$ 580,000
Goodwill				$ 0
Impairment charges - goodwill	$ 0	$ 6,229,000	$ 1,138,000

XML

Intangible Assets and Goodwill - Schedule of Future Amortization Expense (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2023	$ 260
2024	258
Net Carrying Amount	$ 518	$ 604

XML

Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Other Liabilities Disclosure [Abstract]
Compensation costs	$ 779	$ 707
Customer deposits	271	128
Professional fees	344	57
Taxes and regulatory fees	43	59
Other accrued expenses and liabilities	77	123
Rent expense	151	0
Accrued expenses and other liabilities	$ 1,665	$ 1,074

XML

Leases - Narrative (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($) facility	Mar. 31, 2022 USD ($)
Lessee, Lease, Description [Line Items]
Non-cash lease expense | $	$ 46	$ 139
Sublease income | $	16	66
Operating lease, payments | $	$ 100	$ 173
Los Angeles, California
Lessee, Lease, Description [Line Items]
Number of facilities | facility	3
Number of subleases | facility	1
City of Industry, California
Lessee, Lease, Description [Line Items]
Number of facilities | facility	1

XML

Leases - Balance Sheet Information (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Leases [Abstract]
Operating lease - right of use asset, net	$ 99	$ 142	$ 659
Current portion of operating lease liabilities	139	219
Operating lease liabilities, net of current portion	0	17
Total operating lease liabilities	$ 139	$ 236	$ 728

XML

Leases - Table Operating Lease Future Minimum Rental Commitment (Details) - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Leases [Abstract]
2023	$ 125
2024	17
Total lease payments	142
Effect of discounting	(3)
Total lease liability	$ 139	$ 236	$ 728

XML

Leases - Summary of Activity for Our Right of Use Assets And Lease Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Right-of-Use Asset
Beginning balance	$ 142	$ 659	$ 659
Additions	0		11
Terminations and modifications	0
Non-cash lease expense from right-of-use asset	(43)	(127)	(349)
Impairment charges	0		(179)
Ending balance	99		142
Operating Lease Liabilities
Beginning balance	236	$ 728	728
Additions	0		11
Terminations and modifications	0
Non-cash lease expense and payments	(97)		(503)
Impairment charges	0		0
Ending balance	$ 139		$ 236

XML

Capital Stock - Common Stock and Common Stock Warrants (Details) $ / shares in Units, $ in Thousands			3 Months Ended
	Apr. 18, 2023 USD ($) $ / shares shares	Jan. 03, 2023	Mar. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 $ / shares shares	Mar. 31, 2022 shares	Dec. 31, 2021 $ / shares shares	Dec. 06, 2020 $ / shares shares	Oct. 21, 2020 $ / shares shares
Class of Stock [Line Items]
Stockholders' equity note, stock split, conversion ratio		0.06667
Common stock, par value (in dollars per share) | $ / shares			$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)			150,000,000	150,000,000
Common stock, shares issued (in shares)			2,070,861	2,070,861
Common stock, shares outstanding (in shares)			2,063,308	2,063,308
Exercise price (in dollars per share) | $ / shares			$ 6.66	$ 66.34		$ 66.34	$ 82.35	$ 61.20
Warrants outstanding and exercisable, ending (in shares)			4,479,947	343,101		343,101
Warrants issued (in shares)			4,479,947				41,667	34,767
Common Stock
Class of Stock [Line Items]
Common stock, shares outstanding (in shares)			2,071,000	2,071,000	2,071,000	2,071,000
Common Stock | Subsequent Event
Class of Stock [Line Items]
Exercise price (in dollars per share) | $ / shares	$ 1.71
Warrant exercises | $	$ 534
Payments of stock issuance costs | $	$ 46
Warrants outstanding and exercisable, ending (in shares)	3,603
Issuance of common shares from warrant exercise (in shares)	339,498
Issuance of restricted stock (in shares)	177,564
Warrants
Class of Stock [Line Items]
Warrant, Down Round Feature, Increase (Decrease) in Equity, Amount | $			$ 25
Warrants | Private Placement
Class of Stock [Line Items]
Exercise price (in dollars per share) | $ / shares			$ 1.71
Beneficial ownership limitation			4.99%
Warrants issued (in shares)			4,136,846
Warrant term			5 years

XML

Capital Stock - Warrants Outstanding (Details) - $ / shares	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Jun. 30, 2021	Dec. 06, 2020	Oct. 21, 2020
Class of Warrant or Right [Line Items]
Warrants issued (in shares)	4,479,947				41,667	34,767
Exercise price (in dollars per share)	$ 6.66	$ 66.34	$ 66.34		$ 82.35	$ 61.20
Series A Warrants
Class of Warrant or Right [Line Items]
Warrants issued (in shares)				66,667
Exercise price (in dollars per share)				$ 60.00
Series B Warrants
Class of Warrant or Right [Line Items]
Warrants issued (in shares)				200,000
Exercise price (in dollars per share)				$ 66.00
Warrants | Private Placement
Class of Warrant or Right [Line Items]
Warrants issued (in shares)	4,136,846
Exercise price (in dollars per share)	$ 1.71

XML

Capital Stock - Warrants Activity (Details) - $ / shares	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2021	Dec. 06, 2020	Oct. 21, 2020
Number of Warrants
Warrants outstanding and exercisable, beginning (in shares)	343,101
Granted (in shares)	4,136,846
Warrants outstanding and exercisable, ending (in shares)	4,479,947
Warrants outstanding and exercisable, ending (in shares)	4,479,947	343,101
Weighted Average Exercise Price
Warrants outstanding and exercisable, beginning (in dollars per share)	$ 66.34
Granted (in dollars per share)	1.71
Warrants outstanding and exercisable, ending (in dollars per share)	6.66
Warrants outstanding and exercisable, ending (in dollars per share)	$ 6.66	$ 66.34	$ 82.35	$ 61.20

XML

Preferred Stock (Details) - USD ($) $ / shares in Units, $ in Thousands			3 Months Ended
	Mar. 31, 2023	Mar. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 06, 2020	Oct. 21, 2020
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)	42,000		42,000	42,000
Preferred stock, shares designated (in shares)	1,983,250		1,983,250
Preferred stock, shares issued (in shares)	6,550		6,550	0
Preferred stock, shares outstanding (in shares)	6,550		6,550	0
Proceeds from private placement, net of fees and amounts held in escrow			$ 1,473
Exercise price (in dollars per share)	$ 6.66		$ 6.66	$ 66.34	$ 66.34	$ 82.35	$ 61.20
Private Placement | Preferred Warrants
Class of Stock [Line Items]
Number of shares issuable (in shares)	32,750	32,750	32,750
Series F Preferred Stock
Class of Stock [Line Items]
Preferred Stock, Liquidation Preference Per Share	$ 1,000		$ 1,000
Conversion price	$ 1.71		$ 1.71
Preferred stock, conversion price percentage	80.00%		80.00%
Preferred stock convertible, threshold consecutive trading days			30 days
Preferred stock dividend percentage			9.00%
Percentage of common stock to be issued at minimum price	19.99%		19.99%
Exercise price (in dollars per share)	$ 975		$ 975
Percentage of common stock issuable	100.00%		100.00%
Expiration period			3 years
Series F Preferred Stock | Scenario 1
Class of Stock [Line Items]
Preferred stock dividend percentage			20.00%
Series F Preferred Stock | Private Placement
Class of Stock [Line Items]
Number of shares issued (in shares)	6,550	6,550
Proceeds from private placement, net of fees and amounts held in escrow		$ 1,473
Gross proceeds		6,386
Escrow deposit		4,000
Payments of stock issuance costs		$ 913
Percentage of common stock to be issued at minimum price		19.99%
Maximum
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)	5,000,000		5,000,000

XML

Stock Based Compensation - Narrative (Details)		3 Months Ended		12 Months Ended
	Jan. 03, 2023	Mar. 31, 2023 USD ($) $ / shares shares	Mar. 31, 2022 USD ($) shares	Dec. 31, 2022 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stockholders' equity note, stock split, conversion ratio	0.06667
Number of options granted (in shares) | shares		0	0
Vested stock options expired (in shares) | shares		6,501	334	501
Forfeited (in shares) | shares			10,000	10,000
Options, intrinsic value, vested		$ 0	$ 0
Stock option compensation expense, forfeiture			84,000
Unrecognized stock-based compensation expense for stock options		154,000
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option compensation expense		$ 31,000	(32,000)
Stock option compensation expense, gross			52,000
Stock option compensation expense, forfeiture			$ 84,000
Cost not yet recognized, period for recognition		1 year 3 months
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested restricted shares outstanding (in shares) | shares		42
Weighted average price of shares (in dollars per share) | $ / shares		$ 235.87
Vesting period		10 years
Award service period		5 years
Unrecognized stock-based compensation expense for other than options		$ 0
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option compensation expense		$ 0
Unvested restricted shares outstanding (in shares) | shares		0
Unrecognized stock-based compensation expense for other than options		$ 0
Stock-based compensation arrangement, vested in period, remain outstanding (in shares) | shares		1,929
2019 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares) | shares		177,567

XML

Stock Based Compensation - Options Outstanding (Details) - $ / shares	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Number of Options
Outstanding number of options, beginning (in shares)	16,668	27,169	27,169
Granted (in shares)	0	0
Vested (in shares)			0
Expired (in shares)	(6,501)	(334)	(501)
Forfeited (in shares)		(10,000)	(10,000)
Outstanding and exercisable number of options, ending (in shares)	10,167		16,668
Weighted Average Exercise Price
Outstanding weighted average exercise price, beginning (in dollars per share)	$ 143.63	$ 113.63	$ 113.63
Vested (in dollars per share)			0
Expired (in dollars per share)	289.77		410.18
Forfeited (in dollars per share)			48.75
Outstanding and exercisable weighted average exercise price, ending (in dollars per share)	$ 50.17		$ 143.63
Exercisable
Exercisable number of options, beginning (in shares)	10,000	7,169	7,169
Vested (in shares)			3,332
Expired (in shares)	(6,501)		(501)
Exercisable number of options, ending (in shares)	3,499		10,000
Exercisable weighted average exercise price, beginning (in dollars per share)	$ 206.85	$ 0	$ 0
Exercisable vested, weighted average exercise price (in dollars per share)			48.75
Exercisable expired, weighted average exercise price (in dollars per share)	289.77		410.18
Exercisable weighted average exercise price, ending (in dollars per share)	$ 52.87		$ 206.85

XML

Stock Based Compensation - Exercise Price Range (Details) - $ / shares	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of options, outstanding (in shares)	10,167	16,668	27,169
Weighted Average Remaining Contractual Life (In Years)	8 years 1 month 13 days
Weighted average exercise price, outstanding (in dollars per share)	$ 50.17	$ 143.63	$ 113.63
Number of options, exercisable (in shares)	3,499	10,000	7,169
Exercisable weighted average exercise price (in dollars per share)	$ 52.87	$ 206.85	$ 0
$0.00 – $100.00
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of price, lower range limit (in dollars per share)	0.00
Range of price, upper range limit (in dollars per share)	$ 100.00
Number of options, outstanding (in shares)	10,000
Weighted Average Remaining Contractual Life (In Years)	8 years 3 months
Weighted average exercise price, outstanding (in dollars per share)	$ 48.75
Number of options, exercisable (in shares)	3,332
Exercisable weighted average exercise price (in dollars per share)	$ 48.75
$100.01 – $200.00
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Range of price, lower range limit (in dollars per share)	100.01
Range of price, upper range limit (in dollars per share)	$ 200.00
Number of options, outstanding (in shares)	167
Weighted Average Remaining Contractual Life (In Years)	3 months
Weighted average exercise price, outstanding (in dollars per share)	$ 135.00
Number of options, exercisable (in shares)	167
Exercisable weighted average exercise price (in dollars per share)	$ 135.00

XML

Net Loss Per Share - Narrative (Details)		3 Months Ended
	Jan. 03, 2023	Mar. 31, 2023 shares
Earnings Per Share [Abstract]
Stockholders' equity note, stock split, conversion ratio	0.06667
Weighted-average shares common stock outstanding, potentially dilutive securities or unvested restricted stock (in shares)		0

XML

Net Loss Per Share - Computation of Basic and Diluted Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Numerator:
Net loss	$ (1,219)	$ (4,539)
Warrant Modification	(25)	0
Net loss attributable to common stockholders	$ (1,244)	$ (4,539)
Denominator:
Weighted-average number of shares of common stock - basic (in shares)	2,065	2,065
Weighted-average number of shares of common stock - diluted (in shares)	2,065	2,065
Basic net loss per share (in dollars per share)	$ (0.60)	$ (2.20)
Diluted net loss per share (in dollars per share)	$ (0.60)	$ (2.20)

XML

Net Loss Per Share - Effect of Antidilutive Securities (Details) - shares	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Unvested restricted stock awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	42	42
Outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	10,167	16,835
Common stock issuable upon conversion of Series F Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	3,830,409	0
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	4,479,947	343,101

XML

Segment Reporting (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($) segment	Mar. 31, 2022 USD ($)
Segment Reporting Information [Line Items]
Number of operating segments | segment	2
Revenue	$ 1,038	$ 1,532
Cost of revenues	762	1,033
Gross profit	$ 276	$ 499
Gross profit %	27.00%	33.00%
Total operating expenses	$ 1,479	$ 5,021
Loss from operations	(1,203)	(4,522)
Interest and other expense (income), net	(22)	6
Loss before income taxes	(1,181)	(4,528)
Income tax expense	38	11
Net loss	(1,219)	(4,539)
Allocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	286	3,481
Unallocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	1,193	1,540
Unallocated operating expenses
Segment Reporting Information [Line Items]
Revenue	0	0
Cost of revenues	0	0
Gross profit	0	0
Total operating expenses	1,193	1,540
Loss from operations	(1,193)	(1,540)
Interest and other expense (income), net	0	0
Loss before income taxes	(1,193)	(1,540)
Income tax expense	0	0
Net loss	(1,193)	(1,540)
Unallocated operating expenses | Allocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	0	0
Unallocated operating expenses | Unallocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	1,193	1,540
Managed Services | Operating Segments
Segment Reporting Information [Line Items]
Revenue	690	966
Cost of revenues	460	645
Gross profit	$ 230	$ 321
Gross profit %	33.00%	33.00%
Total operating expenses	$ 0	$ 56
Loss from operations	230	265
Interest and other expense (income), net	(3)	(6)
Loss before income taxes	233	271
Income tax expense	7	9
Net loss	226	262
Managed Services | Operating Segments | Allocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	0	56
Managed Services | Operating Segments | Unallocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	0	0
Collaboration Products | Operating Segments
Segment Reporting Information [Line Items]
Revenue	348	566
Cost of revenues	302	388
Gross profit	$ 46	$ 178
Gross profit %	13.00%	31.00%
Total operating expenses	$ 286	$ 3,425
Loss from operations	(240)	(3,247)
Interest and other expense (income), net	(25)	0
Loss before income taxes	(215)	(3,247)
Income tax expense	31	2
Net loss	(246)	(3,249)
Collaboration Products | Operating Segments | Allocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	286	3,425
Collaboration Products | Operating Segments | Unallocated operating expenses
Segment Reporting Information [Line Items]
Total operating expenses	$ 0	$ 0

XML

Segment Reporting - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 1,038	$ 1,532
Product Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 1,038	$ 1,532
Revenue | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue	100.00%	100.00%
Managed Services | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 690	$ 966
Managed Services | Revenue | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue	67.00%	63.00%
Managed Services | Video collaboration services | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 64	$ 116
Managed Services | Video collaboration services | Revenue | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue	6.00%	7.00%
Managed Services | Network services | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 618	$ 821
Managed Services | Network services | Revenue | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue	60.00%	54.00%
Managed Services | Professional and other services | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 8	$ 29
Managed Services | Professional and other services | Revenue | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue	1.00%	2.00%
Collaboration Products | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 348	$ 566
Collaboration Products | Revenue | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue	33.00%	37.00%
Collaboration Products | Video collaboration services | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 348	$ 562
Collaboration Products | Video collaboration services | Revenue | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue	33.00%	37.00%
Collaboration Products | Licensing | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Revenue	$ 0	$ 4
Collaboration Products | Licensing | Revenue | Product Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue	0.00%	0.00%
Domestic
Disaggregation of Revenue [Line Items]
Revenue	$ 563	$ 843
Foreign
Disaggregation of Revenue [Line Items]
Revenue	$ 475	$ 689

XML

Segment Reporting - Concentration Percentage (Details)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenue | Geographic Concentration Risk | UNITED KINGDOM
Concentration Risk [Line Items]
Concentration risk, percentage		12.00%
Customer A | Managed Services | Revenue | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage	52.00%	44.00%
Customer A | Managed Services | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage	41.00%	38.00%
Customer B | Managed Services | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage	11.00%	0.00%
Customer C | Collaboration Products | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage	14.00%	0.00%
Customer D | Collaboration Products | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage	15.00%	0.00%
Customer E | Collaboration Products | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage	0.00%	13.00%
Customer F | Collaboration Products | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage	0.00%	10.00%